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Abstract 
 
Background/Purpose:  Revisions are underway for the two major diagnostic classification 
systems (DCSs) of mental disorders, the International Classification of Diseases (ICD) and the 
Diagnostic and Statistical Manual of Mental Disorders (DSM).  For the World Health 
Organization (WHO), improving clinical utility is a major priority for the ICD-11.  International 
clinician surveys are informative in this regard, but such research has not been conducted among 
psychologists.  This study investigates psychologists’ views on DCSs in mental health care and 
how these views differ across countries, regions, and ICD-10 versus DSM-IV users. 
 
Methods:  WHO and the International Union of Psychological Science conducted an 
international online survey examining views of DCSs as part of the ICD revision process.  
Participants were 2,155 psychologists from 23 national psychological associations around the 
globe.  Items addressed practical and conceptual issues related to DCSs and their clinical use. 
 
Results:  Majorities of participating psychologists were licensed, seeing patients, made 
diagnoses, and used a DCS regularly, the slight majority using the ICD-10 most often.  The vast 
majority viewed the primary purpose of DCSs to be informing treatment decisions and 
facilitating clinical communication.  Flexible diagnostic guidelines were preferred to strict 
criteria.  Most respondents agreed that dimensional classification, severity, and functional 
impairment should be incorporated into a DCS, but with little agreement as to how or why.  
Significant percentages reported problems with their DCS including cross-cultural applicability, 
Western bias, stigmatizing terms, and a need for a national DCS.  Clinicians favorably evaluated 
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the ease of use and goodness of fit of most diagnoses, but identified some as problematic.  There 
were more differences among regions and countries than between ICD-10 and DSM-IV users. 
 
Conclusions:  Overall, psychologists’ views reflect favorably upon the current ICD-10 and 
DSM-IV systems and categories, while also identifying areas for improvement.  Findings 
underscore the priority of clinical utility in a DCS, the diverse purposes it must serve, and 
professional and cultural differences among its international users.  Differences associated with 
countries/regions, DCSs, and psychologists and psychiatrists may be partially explained by 
country-level differences in health systems, cultural factors, and psychology.  Implications for 
ICD-11 revisions, field trials, dissemination, and training efforts are discussed. 
 
Keywords:  International Classification of Diseases (ICD), Diagnostic and Statistical Manual of 
Mental Disorders (DSM), diagnostic classification system, clinical utility, psychologists, cross-
cultural applicability  
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Psychologists’ Perspectives on the Diagnostic Classification of Mental Disorders: 
Results from the WHO-IUPsyS Global Survey 
 
The two major diagnostic classification systems (DCS) for mental and behavioral 
disorders—the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text 
revision (DSM-IV-TR; American Psychiatric Association [APA], 2000) and the International 
Classification of Diseases, Chapter V: Mental and Behavioural Disorders (ICD-10; World Health 
Organization [WHO] 1992a)—are currently under revision.  Currently, the DSM-5 Task Force is 
nearing the conclusion of its field trials process and developing the penultimate draft of the new 
manual, with a scheduled publication date of May 2013 (APA, 2012).  Meanwhile, the ICD-11 is 
undergoing a review and revision of the second (Beta) draft, and WHO is preparing to engage in 
a broad review and comment process and conduct field testing over the next two years, with an 
expected completion date of May 2015 (WHO, 2012).  As their publication dates have drawn 
nearer, there has been an increasing level of scientific, professional, and popular interest in these 
two DCSs, and they have increasingly become foci of critical discussion in the psychological and 
psychiatric literatures.  This discussion has generated controversy and expressions of 
dissatisfaction in regard to the current systems, as well as different recommendations for how 
they should be revised.   
With regard to the DSM-5 in particular, the discussion has evolved into a heated public 
controversy highlighted in numerous popular news media outlets.  Among the many points of 
criticism are fiduciary conflicts of interest among members of DSM-5 work groups (Aldhous, 
2012; Ledford, 2012); concerns regarding new childhood diagnoses, disruptive mood 
dysregulation disorder (Frances, 2011) and attenuated psychosis syndrome (Frances, 2012); and 
removal the bereavement exclusion criterion for depression (Frances, 2010; Granek & O’Rourke, 
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2012; Szalavitz, 2012).  These controversies have fueled popular and professional dissatisfaction 
with the DSM-5, as exemplified in a recent petition, organized largely by individuals and 
organizations in psychology, that expresses several points of protest against the new manual 
(Ledford, 2011; Waters, 2011).  Although many of the points of debate in the popular media are 
beyond the scope and aim of this thesis, the attention drawn underscores the myriad interests at 
stake in revising the DSM-5 or any DCS. 
The main premise underlying these discussions is that revision is not necessarily 
tantamount to improvement.  A poorly informed change could entail negative repercussions 
affecting several sectors of society.  For example, altering a single diagnostic criterion for a 
disorder could lead to (and, in the past, has led to) significant changes in the prevalence of that 
diagnosis; the number of assessments, treatments, and prescriptions administered; the cost to 
patients as well as private and public reimbursement agencies; the revenue generated by 
pharmaceutical companies and healthcare providers; and the characteristics, stigma, and legal 
status associated with the diagnosed population (Frances, 2009; First & Frances, 2008).  On the 
other hand, however, if these systems are not adequately reformulated in the current revision 
processes, the mental health field risks further reification of existing diagnostic constructs that 
are currently lacking in evidence for their biological and nosological validity (Hyman, 2010).  In 
light of the far-reaching social, financial, and clinical implications of the classification and 
diagnosis of mental disorders, the present question of how best to revise these systems is a matter 
of great significance not only for those affiliated with the mental health care field, but for the 
general public as well. 
 Commensurate with the gravity of the above considerations, APA and WHO have 
approached their respective revision processes with a degree of careful planning and 
deliberation.  Although the methods and objectives of the ICD and DSM revision processes differ 
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in many ways, they are similar in some respects.  For both, the revision process began well over 
ten years prior to publication, and has included establishing a research agenda and identifying 
key priorities and goals for the new editions (Kupfer, First, & Regier, 2002; Kupfer, Regier, & 
Kuhl, 2008; International Advisory Group, 2011; Reed, 2010; Reed, Sharan, & Saxena, 2009).  
Most of these goals aimed to improve the scientific validity and/or clinical utility of the 
classifications—two complementary yet sometimes competing priorities of psychiatric nosology 
(Kendall & Jablensky, 2003).  Specifically, early in the revision processes, there was a focus on 
increasing validity and reliability through incorporating recent research on biological etiology 
and markers from fields such as genetics and neuroscience (e.g., Andrews et al., 2009; Hyman, 
2010; Insel et al., 2010; Insel & Wang, 2010).  Such a paradigm shift, it was hoped, could 
advance the science of diagnostic classification from diagnostic reliability (a major 
accomplishment of the last two generations of the DSM and ICD) to biological validity, which is 
sometimes considered the ideal standard of medical pathology and diagnosis.  Unfortunately, as 
the publication dates have drawn nearer it has become increasingly clear that the progress made 
in these young sciences would be insufficient to effect major change in either DCS (Hyman, 
2010; Insel et al., 2010; Reed, 2010; Rutter, 2011).  While reliability and validity would remain 
integral components of mental health diagnosis and classification, any improvements in these 
dimensions were not likely to come from new findings in the biological sciences. 
  Subsequently, revisers of the DSM and ICD have renewed their focus on another central 
goal of both DCSs, clinical utility—a goal which is directly linked to mental health service 
delivery and WHO’s global public health mission (Reed, 2010).  While several definitions of 
clinical utility have been put forward (e.g., First et al., 2004; Mullins-Sweatt & Widiger, 2009), 
Reed’s (2010) definition is particularly useful for the present study because it is operationalized 
specifically for research on the clinical utility of the ICD.  According to this definition,  
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the clinical utility of a classification construct or category for mental and behavioral 
disorders depends on: a) its value in communicating (e.g., among practitioners, patients, 
families, administrators); b) its implementation characteristics in clinical practice, 
including its goodness of fit (i.e., accuracy of description), its ease of use, and the time 
required to use it (i.e., feasibility); and c) its usefulness in selecting interventions and in 
making clinical management decisions. (p. 461) 
Indeed, as many have noted, both DCSs acknowledge the importance of clinical utility within 
their pages.  The DSM-IV-TR states that its “highest priority has been to provide a helpful guide 
to clinical practice” (APA, 2000, p. xxiii); similarly, the ICD-10-CM was published specifically 
for “general clinical, educational and service use” (WHO, 1992b, p. 8).  In accordance with these 
objectives, many have identified clinically pertinent problems of the current systems and argued 
for revisions that would facilitate greater clinical utility (e.g., First, 2005, 2010; First & Westen, 
2007; Flanagan & Blashfield, 2010; Mullins-Sweatt & Widiger, 2009; Reed, 2010). 
A further consideration, of primary importance for the ICD revision process, is WHO’s 
global public health mission to help relieve the burden of mental illness, particularly in areas 
where treatment needs often go unmet.  Worldwide, the ICD is used for a range of purposes, 
including mental health diagnosis, treatment, billing, and reporting of health statistics.  Thus, to 
the extent that the ICD-11 can be easily used for these purposes in diverse health professions, 
languages, and cultures, this may help to improve the quality and scope of care provided 
(International Advisory Group, 2011; Reed, 2009; Saxena & Reed, 2011). 
Problems and Solutions  
 There is no shortage of criticisms of the DSM-IV and ICD-10, nor is there a limited 
number of recommendations for how they might be improved.  A full review of this literature is 
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clearly beyond the scope of this paper.  However, for illustrative purposes, a few of the issues 
addressed by the present study are briefly summarized below. 
 One common criticism of the DSM and the ICD is that they are too large and complex to 
be optimally useful in most clinical settings (Andrews, Anderson, Slade, & Sunderland, 2008; 
Flanagan & Blashfield, 2010; Watson & Clark, 2006; Zimmerman, Chelminski, McGlinchey, & 
Young, 2006).  This may be especially problematic for those clinicians who are not mental 
health specialists and do not receive much training in these manuals—yet these are the same 
clinicians carrying the majority of the global mental health care burden (Wang et al., 2007; 
WHO, 2011).  Both systems contain hundreds of diagnostic categories arranged across multiple 
hierarchical levels of organization, with each disorder defined by elaborate diagnostic 
requirements.  However, there is evidence suggesting that clinicians do not rigidly adhere to the 
formal diagnostic procedures and nosologies in which they were trained; rather, they develop and 
use their own diagnostic methods and cognitive DCSs, which appear to be more parsimonious, 
flexible, pragmatic, and informed by experience—for better or for worse (First & Westen, 2007; 
Garb, 2005).   
 For instance, Flanagan and colleagues’ (2007a, 2007b, 2008, 2010) research suggests that 
most clinicians develop “folk taxonomies” of mental disorders, forming groups based on 
perceptions of clinical similarity among disorders (e.g., conduct disorder and oppositional defiant 
disorder).  These taxonomies tend to be smaller and simpler than the ICD-10 and DSM-IV 
taxonomic structures.  More recently, two similar investigations (Reed et al., 2012; Roberts et al., 
2012) have found that mental health professionals conceptualize relationships among disorders 
in ways that are remarkably consistent with one another—even across countries, professions, and 
languages—and less consistent with the ICD-10 and DSM-IV.  There is also empirical evidence 
to suggest that some diagnostic criteria may be simplified in a manner that improves utility 
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without compromising reliability (Andrews et al., 2008; Zimmerman et al., 2006).  Therefore, if 
it is true that clinicians’ folk taxonomies and diagnostic practices are indeed simpler and more 
clinically useful than the official taxonomies, then for the DSM-5 and ICD-11, a simplification of 
some kind may be in order. 
 Other recommendations for improving the overall clinical utility of the DSM and ICD 
include the incorporation of various alternative conceptual approaches to defining the nature and 
degree of mental disorders.  For example, the longstanding discussion of dimensional versus 
categorical classification has intensified in recent years, with many advocating that the DSM-5 
and ICD-11 incorporate dimensional components into their predominately categorical nosologies 
(Brown & Barlow, 2005; Cuthbert, 2005; First, 2005; Kupfer, 2005; Maser et al., 2009; Watson 
& Clark, 2006; Widiger & Samuel, 2005).  Still, the question of whether dimensional 
classification would be more useful than categorical classification remains a matter of debate.  
Within the context of dimensional assessment, different global aspects of mental illness, such as 
severity and functional status, have been identified as clinically significant areas of concern that 
warrant more attention from a DCS (e.g., First & Westen, 2007).  Revisions targeting general 
issues such as these (i.e., dimensional classification, functional impairment, severity) could take 
place at different levels within a DCS, from disorder-specific modifications to broad changes 
affecting the entire system.  
 Finally, clinical utility could be improved by tailoring DCSs to meet the needs and 
purposes of all those who use or are affected by it.  These parties include different providers of 
mental health care (e.g., psychologists, psychiatrists, primary care physicians, social workers, 
psychiatric nurses); patients/clients and their families and advocates; and administrative staff.  
They represent an array of clinical settings, professions, practices, geographic locations, and 
socio-demographic characteristics (e.g., ethnicity, language, culture, socio-economic status, age).  
   7 
Meeting clinicians’ needs in all such circumstances presents a formidable challenge for any 
DCS.  WHO has pursued this goal by tailoring versions of the ICD-10 to the needs of different 
clinical users in different settings and professions (WHO, 1992b; WHO, 1996).  Moreover, the 
ICD-10 is available in 42 languages and in a variety of formats.  With the publication of the 
ICD-11, WHO aims to produce materials that would make their systems more widely accessible 
and satisfactory.  Still, questions remain as to how these and many other goals are best achieved, 
and they seem most appropriately addressed to the different clinical users of these systems. 
Clinicians’ Perspectives 
Some of the more rigorous research on clinicians’ views of DCSs comes from their field 
trials.  The results of the international ICD-10 field trials suggested there was promising clinical 
utility for the newly revised system, specifically in terms of good reliability, ease of use, 
goodness of fit, and positive feedback from clinicians (Sartorius et al., 1993).  Studies such as 
this offer advantages in size, resources, and methodological design, but are also expensive, rare, 
and tailored for the specific purposes of testing and finalizing a new DCS.  Moreover, they have 
tended to prioritize reliability and validity while under-emphasizing clinicians’ opinions on 
substantive issues of diagnostic classification. 
A more common and feasible method for addressing some of these questions is through 
surveys of clinicians.  To date, there have been relatively few studies of this type, and they have 
often limited by their sample size, methods, or geographical scope.  In one of the earliest of these 
studies, Maser, Kaelber, and Weise (1991) surveyed 146 people from 42 countries and found that 
the DSM-III and DSM-III-R, in comparison with the ICD-9, were more frequently identified as 
useful for clinical, research, and educational purposes.  Respondents also responded favorably to 
the overarching features of the DSM.  However, this study’s methodological limitations likely 
resulted in a biased and non-representative sample, which makes the results difficult to interpret.  
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With the publication of the ICD-10, the ICD system has emerged as that which is most 
frequently used in clinical settings throughout the world.  In a survey of French psychiatrists, 
Sechter (1995) found that, although many used the DSM-III-R for research purposes, the ICD-10 
was used more frequently for clinical practice and in medical settings.  After the publication of 
the DSM-IV and DSM–IV-TR, the international shift toward preferring the ICD system in mental 
health care continued to become more evident (Mezzich, 2002; Müssigbrodt et al., 2000).  More 
recently, Zielasek and colleagues (2010) similarly found general satisfaction with most aspects 
of the ICD-10 among a sample of German-speaking psychiatrists in three countries.   
Only recently have a few clinician surveys moved beyond questions of usage and 
satisfaction to examine opinions on more substantive issues about diagnostic classification and 
clinical utility.  Mellsop and colleagues (2007b) developed a questionnaire to examine New 
Zealand psychiatrists’ views on the purposes, problems, and design of DCSs, as well as how they 
could be changed in order to better serve their clinical functions.  Adaptations of this 
questionnaire have subsequently been used to examine psychiatrists’ views across different 
geographical and cultural contexts, including New Zealand, Brazil, and Japan (Mellsop et al., 
2007a), the United States (Bell, Sowers, & Thompson, 2008), and Japan, Korea, China, and 
Taiwan (Suzuki et al., 2010).  In all of these studies, clinicians consistently indicated that inter-
clinician communication was the most important purpose of a DCS and that they wanted a 
simple, reliable, and easy-to-use system with fewer disorder categories.  However, there was less 
agreement on how best to tailor a system to meet the needs of different users, and views on 
cross-cultural applicability varied across different countries and cultural contexts.  In the most 
recent adaptation of this survey, Mellsop, Lutchman, Lillis, and Dutu (2011) examined and 
compared the views of psychiatrists, primary care physicians, clinical psychologists, and 
consumers in New Zealand.  Although they found some differences between groups (e.g., 
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psychologists emphasizing research and health statistics more than psychiatrists), all samples 
again agreed that inter-clinician communication is the most important purpose. 
Recently, WHO and the World Psychiatric Association (WPA) conducted the largest 
clinician survey to date, involving 4,887 psychiatrists in 44 countries around the globe (Reed, 
Correia, Esparza, Saxena, & Maj, 2011).  Consistent with the findings of previous surveys, Reed 
et al. (2011) found that the majority of respondents agreed that the most important purposes of a 
DCS were to facilitate inter-clinician communication and to inform clinical treatment and 
management decisions.  Similarly, respondents preferred flexible (rather than strict) diagnostic 
guidelines and a simplified system with fewer diagnostic categories.  There was disagreement 
regarding whether/how to incorporate dimensional classification, functional impairment, and 
severity into the ICD and DSM.  In general, these findings underscored the priority of clinical 
utility, were favorable for most diagnostic categories, and reflected the current controversies and 
debates within the mental health field. 
 With the exception of Mellsop et al. (2011), most of the previous surveys of mental 
health clinicians’ views on DCSs have been conducted with samples comprised entirely or 
mostly of psychiatrists; few have included psychologists, not to mention the many other health 
professionals who often provided mental health services (e.g., clinical social workers, general 
practitioners counselors, psychiatric nurses).  This is an important limitation because, worldwide, 
psychiatrists provide only a small fraction of the mental health services delivered (WHO, 2011), 
and represent only one of several perspectives in mental health care.  In addition to psychiatrists, 
psychologists represent a significant constituency among those who use these DCSs, and they 
may offer a valuable perspective on how to improve their clinical utility.  Additionally, given 
that a considerable amount of the protest against the DSM-5 revisions has come from 
professional organizations and individuals within psychology (Coalition for DSM-5 Reform, 
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2012), it seems that many psychologists are dissatisfied with the current revision efforts and 
interested in sharing their own views to help improve diagnostic classification.  In light of these 
considerations, a large-scale investigation of psychologists’ views is an important next step for 
this emerging literature and for the future of diagnostic classification. 
 Previous studies in this area have two further limitations.  First, most have examined 
clinicians in only one or a few countries or geographical regions.  Second, the majority of these 
studies have been conducted with samples that generally use the same DCS, or researchers have 
neglected to examine any differences between DSM users and ICD users.  To date, Reed et al. 
(2011) is the first and only study with sufficient sample size and diversity to investigate either of 
these issues, and the findings posed interesting implications for psychiatry around the globe and 
across cultures.  Similar research is needed to better understand psychologists’ views across 
regions, countries, and DCSs. 
Overview of the Present Study 
 As the mental health care field anticipates the DSM-5 and ICD-11, there is a need for 
research examining how altering the general features of those systems could affect their clinical 
utility.  Reed et al. (2011) took an important step in this direction with the first global survey of 
psychiatrists.  This study represents the next major step in this emerging body of research: a 
global survey of psychologists.   
 Specifically, the aims of the present study were (a) to examine psychologists’ opinions on 
issues concerning the clinical utility of DCSs, and (b) to determine whether and to what extent 
these opinions differ across geographical region, country, and users of different DCSs.  These 
data (along with data from other investigations from the ICD-11 formative research program 
[Reed et al., 2011, 2012, Roberts et al., 2012]), will be used to help inform revisions to the 
forthcoming ICD-11 chapter on mental and behavioural disorders, as one part of the effort to 
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facilitate greater clinical utility.  To this end, an online survey for psychologists was developed 
and distributed by WHO, the International Union of Psychological Science (IUPsyS), and 23 
national psychological associations.  The final sample consisted of over 2,155 psychologists 
from 23 countries, representing a diverse range of social, economic, cultural, and professional 
backgrounds.  Survey items addressed topics such as the usage and purposes of DCSs, as well as 
practical and conceptual issues of mental disorder classification.  The study also examined the 
prevalence, ease of use and goodness of fit of particular disorders, and explored areas of 
dissatisfaction with and recommendations for improving the current systems.   
Methods 
 As detailed below, the methods for developing and distributing the survey are similar to 
those described in the WHO-WPA global survey of psychiatrists (Reed et al., 2011), but with 
differences relating to the participants, organizations, and time frame.  Prior to data collection, all 
procedures and materials received approval from the WHO Research Ethics Review Committee 
(ERC) and the University of Kansas Human Subjects Committee – Lawrence (KU HSC-L). 
Survey Development 
 Before developing the survey, three of the investigators (Drs. Pierre Ritchie and Ann 
Watts, IUPsyS; and Dr. Geoffrey Reed, WHO) composed and sent letters to the presidents of 
IUPsyS member (national psychological) associations to assess their interest in participating in 
various international research projects for the ICD revision, including the present study.  
Recipients were asked to indicate their association’s level of interest and ability regarding 
participating in a global survey of psychologists’ experiences and attitudes regarding the ICD-10, 
DSM-IV, and other DCSs of mental disorders.  Associations unable to participate in an English-
language survey were asked if they could translate it to the language used by most of their 
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members.  In total, 47 societies expressed interest, and 23 ultimately implemented the survey to 
completion (see Table 1). 
 The online survey was developed by the WHO Department of Mental Health and 
Substance Abuse as a means to allow clinician input to influence revisions to the ICD chapter on 
mental and behavioral disorders.  It included content adapted from similar previous surveys of 
clinicians (Mellsop et al., 2007a, 2007b; Reed et al., 2011; Zielasek et al., 2010) and the ICD-10 
field trials (Sartorius et al., 1993) of the Clinical Descriptions and Diagnostic Guidelines (WHO, 
1992b).   The current survey was tailored specifically for psychologists, including the addition of 
new questions specifically relevant to psychology practice. 
 All surveys were programmed and administered through the Qualtrics web-based survey 
platform, hosted through an account licensed to the University of Kansas.  Where appropriate, 
the survey was programmed to be adaptive to participants’ responses, such that some items were 
presented only if certain responses were selected for previous items (see Appendix footnotes).  
For example, if respondents indicated that they were not currently seeing patients, they were not 
presented with the items asking about their clinical experiences with particular diagnostic 
categories.  The survey was also programmed to require participants to provide a response to all 
items before moving on to the next screen, a method which has been shown to reduce missing 
data without affecting survey completion rate (Albaum, Wiley, Roster, & Smith, 2011). 
 The survey was originally developed in English, and 17 out of the 23 societies 
implemented the English version of the survey only.  For the other six countries, survey 
materials were translated into Spanish, French, German, and Turkish (see Table 1).  The Spanish 
and French translations were provided by WHO.  The German and Turkish translations were 
adapted by the national psychological associations in Germany and Turkey from translations 
used for the Reed et al. (2011) survey of psychiatrists.  To facilitate these translations, WHO 
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provided explicit instructions that included forward- and back-translation, attention to conceptual 
equivalence across cultures, semantic equivalence across languages, and the use of multiple 
translators, with procedures to resolve differences.  
Survey Content 
Despite the different translations, all participants were presented with the same survey, 
which consisted of an introduction page followed by four sections (see Appendix).  The 
introduction page presented participants with a brief description of the purposes of the study and 
the content of the questionnaire, followed by instructions and the opportunity to agree or decline 
to participate.  The remaining sections were collectively designed to address the content areas of 
sample demographics, professional characteristics, usage of a DCS, global features of a DCS, 
cultural concerns, and usage and evaluation of particular categories. 
Section One contained multiple-choice items on personal demographic characteristics 
(i.e., age, gender) and information on participants’ clinical practices.  These included items 
pertaining to years of professional experience; whether seeing patients/clients was a regular 
professional activity; if so, how many hours per typical week were spent seeing patients/clients; 
and usage and knowledge of particular DCSs.  In light of the variability of professional 
psychology across countries, additional items were added to this section to assess participants’ 
licensure status, roles in diagnostic decision-making, and diagnostic practices in the settings in 
which they work. 
Section Two consisted of multiple-choice items assessing participants’ opinions on 
general issues relating to DCSs and their use in clinical practice.  For example, these questions 
inquired about the most important purposes of a DCS; how best to accommodate the needs and 
purposes of different users; the optimal number of diagnostic categories; whether diagnostic 
criteria ought to be more rigid or flexible; whether and how to incorporate considerations of 
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functional status, severity, and dimensional classification; whether it is problematic to apply the 
DCS across cultures, races, and ethnicities; and whether a diagnosis of depression should be 
made when the depressive symptoms are a proportionate response to adverse life events such as 
divorce or the loss of a job or home. 
Section Three began by presenting a list of 44 or 45 common diagnostic categories (e.g., 
major depressive disorder, social phobia) from the ICD-10 or DSM-IV, respectively (whichever 
system the participant reports using most often).  From that list, clinicians were asked to select 
the diagnostic categories they regularly encountered among their patients or clients as part of 
their day-to-day practice.  Then, for each diagnostic category selected, participants were asked to 
assess ease of use (i.e., how easily it is used in clinical practice) and goodness of fit (i.e., its 
accuracy in defining, describing, and diagnosing the disorder) on scales of 0 (low) to 3 (high).   
Section Four contained items pertaining to the possible addition, deletion, or re-
organization of disorder categories within the DCS, allowing for both yes/no and open-ended 
responses.  Other questions addressed whether there are particular diagnostic categories that are 
problematic or dissatisfying, whether certain terms in the DCS are stigmatizing in a given 
cultural context, and whether a DCS ought to be tailored to meet the needs of each specific 
country.  Lastly, an opportunity was given to provide comments about the survey. 
Procedures and Participants 
 Participating IUPsyS member associations received a standard set of instructions for the 
selection of participants, initial solicitation message, reminder messages, and tracking of 
participation.  To the fullest extent possible, survey distribution materials and instructions were 
provided in the language of the survey, although some associations helped to modify their 
translations.  The instructions indicated that the primary purpose of the study was to “assess the 
views and opinions of psychologists around the world regarding the problems with current DCSs 
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and to provide scientific and clinical input to strengthen, broaden, and improve the revision 
process.”  In exchange for their participation, member associations were told they would receive 
a database containing the results obtained from their sample, which they could freely present or 
publish as desired, provided that this occur after the publication of the present study and with 
proper approval and acknowledgement of WHO and IUPsyS.   
 Eligible participants were identified by their national psychological associations, who 
were instructed to select participants who met the following inclusion criteria: (a) membership in 
their national psychological association, (b) professional status as a psychologist in their country, 
(c) completion of all necessary professional training, (d) authorization or licensure to practice as 
a psychologist in their country, and (e) current provision of treatment or assessment services for 
mental and behavioural disorders in their country.  National psychological associations were 
instructed that they should not solicit participation from members who were not psychologists, 
still in training, or not currently practicing.  However, not all associations had the membership 
data necessary to ensure that all these criteria were met. 
 Each national association received one of two possible sets of instructions depending on 
the size of their memberships.  Large societies (≥1,000 members) were asked to randomly select 
500 individuals from their membership who satisfied the above criteria for participation.  Small 
societies (<1,000 members) were asked to solicit all available members who met these criteria.  
Once a member association had identified the list of potential participants, those individuals 
received emails soliciting their voluntary participation in a brief online survey that would help 
inform WHO’s revision process for the ICD chapter on Mental and Behavioural Disorders.  Two 
reminder emails were distributed two and six weeks following the initial solicitation.  All emails 
contained an explanation of the purpose of the study, anonymous and voluntary participation, 
time required, approval and exemption status from the WHO ERC and the KU HSC-L, names of 
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investigators, and contact information for any questions or comments.  Throughout the process 
of implementing the survey, participating societies were instructed to keep records of the dates 
and numbers of initial solicitations and reminders sent, as well as the emails returned as 
undeliverable.  Due to technological barriers, one sample (Uganda) implemented a paper-and-
pencil version of the survey delivered by mail.  Still, they were given the same directions as the 
associations using the web-based survey.  Each association’s data collection occurred over a 
period between December 2010 and February 2012 (median data collection period = 3 months).   
Data Analyses 
 For the purposes of geographical and cross-cultural comparison of results, participating 
national psychological associations were a priori assigned to groups according to their 
geographical region.  Regional demarcations were originally derived from WHO’s six official 
world regions (Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, and Western 
Pacific), with slight modifications due to geographical, cultural, and sample considerations.  The 
final six regions used in this study were Africa, Asia, Eastern Mediterranean, Europe, Latin 
America, and the United States (USA; see Table 1 for constituent countries).  
 All descriptive results for the regional and overall samples were calculated in two ways: 
(a) unweighted figures, which combine all participants’ data from constituent countries into one 
group for the purposes of analysis; and (b) weighted figures, in which analyses draw upon 
statistics from the country samples, rather than participant-level data.  Weighted estimates 
overcome the problem of disparate sample sizes by giving each national sample “equal weight” 
in representing the group.  However, these figures should be interpreted cautiously when sample 
sizes are very disproportionate.  By comparing weighted and unweighted estimates, it is possible 
to determine whether the total, unweighted values are disproportionately influenced by countries 
with large sample sizes, and thereby arrive at a more accurate estimate of regional and 
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international results.  Note that weighted estimates are not calculable for comparisons between 
ICD-10 and DSM-IV users because different DCSs were used within most national samples. 
 In addition to descriptive results, Chi-square and ANOVA analyses were conducted on 
categorical and continuous variables, respectively, in order to identify any overall significant 
differences (a) between ICD-10-users and DSM-IV-users, or (b) among all six geographical 
regions.  Due to the large variability in country sample sizes, no statistical analyses were 
conducted at the country level.  To control for an inflated Type I error rate due to numerous 
comparisons and a large sample, all statistical tests were conducted using the Bonferroni 
correction; an alpha level of .0005 was used for all analyses, thereby maintaining a study-wise 
alpha of less than .05.  Where significant differences on survey items were found, effect sizes 
were calculated in the forms of Cramer’s V for categorical variables and Cohen’s d for 
continuous variables.  Following Cohen’s (1988) recommendations, a Cramer’s V >.1 is 
interpreted as a small effect size, >.3 as medium, and >.5 as large; and a Cohen’s d >.2 is 
interpreted as a small, >.5 as medium, and >.8 as large. 
Results 
The final international sample consisted of 2,155 participants (MAge = 44.18, SD = 12.06; 
70.4% female) comprised of national subsamples (M subsample size = 93.70, range = 3 – 343) 
from 23 countries and six major geographical regions around the globe.  Table 1 presents 
demographic and professional characteristics of the overall sample as well as national and 
regional subsamples.  
Response Rate 
 The 23 participating psychological associations recorded a total of 6,911 solicitations by 
email and 40 by mail.  For two associations, India and Israel, solicitation data were not recorded, 
but response data were collected from 54 and 40 participants, respectively.  Thus, the true total 
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number of solicitations, across all countries and modes of participation, was at least 7,045.  
Among the 6,911 psychologists who received the email solicitation, 2,238 (32.4%) clicked on 
the survey link, and 2,135 (30.9%) provided consent to participate in the study.  Among the 
paper-and-pencil participants, 20 out of 40 gave consent.  Thus, the total sample size, including 
online and paper-and-pencil survey participants, was 2,155.  Omitting data from those two 
subsamples for which solicitation figures were not tracked (n = 94), the overall response rate was 
29.7% (weighted = 35.9%), with national subsamples ranging from 8.0% (Ireland) to 76.9% 
(Estonia).   
To determine whether response rates were affected by economic or technological 
differences among countries, national subsamples were compared by country income level 
(World Bank, 2012).  Interestingly, response rates were much higher among low- and lower-
middle-income countries (50.0%; 47.9% weighted) than they were among upper-middle- 
(26.4%; 33.1% weighted), and high-income countries (29.2%; 33.9% weighted).  Given the 
advantages of an online study, it was also possible to calculate how long it took each participant 
to complete the survey.  However, because it is possible for participants to close out of the 
survey or leave it open for long periods of time, response time was only calculated for those who 
spent 5 – 120 minutes on the survey site.  The overall mean response time was 22.20 minutes 
(weighted M = 23.01, SD = 17.6), with a median of 16.37 minutes (weighted median = 18.32). 
 Although a total of 2,155 participants provided consent, 2,012 (93.4%) participants then 
went on to provide responses to one or more subsequent items, and only 1,605 (74.5%) 
completed the entire survey (i.e., submitted the survey or completed the last item).  Such patterns 
of participant dropout are not unusual in online survey research (Hoerger, 2010).  The forced-
response programming of the survey minimized missing data for most items, but there was still a 
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gradual, linear pattern of participant attrition throughout the survey.  ANOVAs and Chi-squares 
were conducted to determine whether differential dropout rates might result in sample bias.   
Dropout was not significantly associated with country income level, gender, DCS, or with 
whether or not respondents were seeing patients; but was related to regional differences, Χ
2 
(5, N 
= 2,155) = 68.89, p < .0005, Cramer’s V (hereafter referred to as ‘V’) = .179, age, F (1, 2010) = 
13.96, p < .0005, Cohen’s d = .207, and experience, F (1, 2005) = 13.47, p < .0005, Cohen’s d = 
.204.  Specifically, completion rates were lower among Eastern Mediterranean (52.7%) and Latin 
American (70.3%) samples than in European (76.9%), Asian (79.1%), American (81.5%) and 
African (81.0%) samples.  Further, survey completers were slightly older (MAge = 44.68 years, 
SD = 11.8) and more experienced (MExperience = 15.42 years, SD = 10.9) than non-completers 
(MAge = 42.19, SD = 12.794;. MExperience = 13.20, SD = 10.996).  It should be noted, however, that 
these differences are all of small magnitude. 
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Table 1: Sample Characteristics by Country and Region 
REGION 
   Country 
Participating 
Psychological 
Association 
Survey  
Language 
N  
Response 
Rate  
(%) 
% of 
Total 
Sample 
M 
Age 
M Years of 
Experience  
% 
Female 
% 
Licensed  
% Seeing 
Patients 
AFRICA          
 Namibia Psychological Association of 
Namibia 
English 7 21.9 0.3 39.9 8.1 85.7 100.0 85.7 
 South Africa Psychological Society of South 
Africa 
English 91 18.8 4.2 48.3 14.1 68.6 96.5 94.2 
 Uganda Uganda National Psychological 
Association 
English 20 50.0 0.9 41.1 7.9 40.0 85.0 90.0 
 Zimbabwe Zimbabwe Psychological 
Association 
English 3 21.4 0.1 40.5 4.0 0.0 100.0 100.0 
 Unweighted M/total 
a --- --- 121 21.2 5.6 46.4 12.7 63.5 94.8 93.0 
 Weighted M --- --- 30.3 28.0 1.4 42.4 8.5 48.6 95.4 92.5 
ASIA          
 Hong Kong Hong Kong Psychological 
Society 
English 72 23.9 3.3 41.6 12.3 82.9 98.6 92.9 
 India India National Academy of 
Psychology 
English 54 Unknown 2.5 39.3 12.0 70.2 97.9 91.5 
 Sri Lanka Sri Lanka Psychological Society English 13 72.2 0.6 40.5 6.8 63.6 90.9 72.7 
 Unweighted M/total
 a --- --- 139 43.6 6.5 40.6 11.7 76.6 97.7 90.6 
 Weighted M --- --- 46.3 48.1 2.2 40.4 10.4 72.2 95.8 85.7 
EASTERN MEDITERRANEAN          
 Israel Israel Psychological Association English 40 Unknown 1.9 53.2 19.9 54.8 96.8 100.0 
 Lebanon Lebanese Psychological 
Association 
English & 
 French 
10 33.3 0.5 40.3 11.7 90.0 100.0 100.0 
 Turkey Turkish Psychological 
Association 
Turkish 174 38.8 8.1 36.7 11.4 75.5 89.8 92.4 
 Unweighted M/total 
a --- --- 224 46.9 10.4 39.6 12.8 72.9 91.5 94.0 
 Weighted M --- --- 74.7 36.1 3.5 43.4 14.3 73.4 95.5 97.5 
EUROPE          
 Denmark Danish Psychological 
Association 
English 223 50.9 10.3 47.1 14.5 77.5 97.2 98.6 
 Estonia Union of Estonian Psychologists English 10 76.9 0.5 43.6 15.6 77.8 100.0 100.0 
 Finland Finnish Psychological Society English 186 41.3 8.6 43.6 15.1 79.8 98.3 96.6 
 France French National Committee of 
Scientific Psychology 
French 343 65.6 15.9 39.9 10.9 76.7 95.5 95.5 
 Germany Federation of German 
Psychologists' Associations 
German 170 34.8 7.9 50.6 19.2 53.9 94.6 89.8 
 Ireland Psychological Society of Ireland English 40 8.0 1.9 45.7 16.3 78.4 94.6 94.6 
 Norway Norwegian Psychological 
Association 
English 239 48.6 11.1 42.5 11.5 67.7 99.6 97.0 
 Sweden Swedish Psychological Society English 100 20.0 4.6 44.3 10.8 67.7 100.0 97.8 
 Switzerland Swiss Psychological Association English 37 14.3 1.7 47.9 18.2 61.8 100.0 97.0 
 United Kingdom British Psychological Society English 50 11.4 2.3 44.0 13.7 70.2 100.0 95.7 
 Unweighted M/total 
a --- --- 1398 15.6 64.8 44.2 13.7 71.6 97.4 95.9 
 Weighted M --- --- 139.8 37.2 6.5 44.9 14.6 71.1 98.0 96.2 
LATIN AMERICA          
 Argentina Argentinean Association of 
Behavioral Science 
Spanish 26 60.5 1.2 41.4 12.3 68.0 100.0 84.0 
 Mexico Mexican Psychological 
Association 
Spanish 139 31.2 6.5 44.1 16.8 66.1 93.7 66.9 
 Unweighted M/total 
a --- --- 165 33.8 7.7 43.7 16.1 66.4 94.7 69.7 
 Weighted M --- --- 82.5 45.9 3.8 42.8 14.5 67.1 96.9 75.5 
USA          
 United States American Psychological 
Association 
English 108 10.9 5.0 54.5 20.9 57.5 100.0 94.3 
OVERALL          
 Unweighted M/total 
a --- --- 2155 31.0 100.0 44.2 14.0 70.4 96.6 93.2 
 M weighted by country --- --- 93.7 35.9 4.3 43.9 13.2 66.7 96.9 92.5 
 M weighted by region --- --- 359.2 28.7 16.7 44.8 14.6 68.1 96.0 89.6 
a
 In these rows, sample size (N) and % of total sample are total values, and all other figures are unweighted means. 
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Professional Characteristics and Practices 
 Clinical experience.  A major priority of this study was to obtain data from mental health 
professionals working with clients/patients in clinical settings.  Accordingly, several items 
addressed participants’ professional characteristics and clinical activities.  Globally, 93.1% 
(92.5% weighted) and large majorities of each country sample (range = 66.9 – 100.0%) were 
currently seeing patients.  Moreover, an even greater majority, 96.6% of participants (96.9% 
weighted), were currently licensed or authorized to provide assessment or treatment services to 
persons with mental disorders, whether independently (86.7%; 84.1% weighted) or under 
supervision (9.9%; 12.9% weighted).  Significant differences were found across regions, Χ
2
 (5, N 
= 1,998) = 147.63, p < .0005, V = .272, such that 69.7 % (75.5% weighted) of respondents in 
Latin American countries reported seeing patients, compared to 90.6 – 95.9% (85.7 – 96.2% 
weighted) of respondents among all other regional samples.  To gauge participants’ level of 
clinical exposure and experience, the survey asked how many years of experience participants 
had and, for those who were currently practicing, how much time they spent seeing patients each 
week.  Overall, respondents had an average of 13.97 years of experience (weighted M = 13.22, 
range = 0 – 60, SD = 10.93).  With regard to weekly clinical activities, 75.2% (66.3% weighted) 
of practitioners reported that they spend between 10 and 40 hours per week seeing patients, with 
a plurality (40.0%; 35.3% weighted) spending 10 – 19 hours per week.  
 Diagnostic practices.  Because psychologists’ roles and backgrounds can vary greatly 
within global mental health care (Stevens & Wedding, 2004), respondents were asked to indicate 
which professionals typically make diagnoses in the setting where they practice most, and what 
role psychologists play with regard to diagnostic decision-making.  Among the entire sample, 
respondents reported that in the settings where they worked most, psychologists (75.0%; 79.2% 
weighted) typically made diagnoses, followed by psychiatrists (60.4%; 56.8% weighted), other 
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physicians (20.0%; 17.7% weighted), “other” (6.8%; 6.9% weighted) and nurses (3.8%; 2.7% 
weighted).  This rank ordering remained consistent across each regional subgroup, but there were 
significant regional differences in the degree to which respondents indicated that psychologists 
[Χ
2 
(5, N = 1,817) = 79.08, p < .0005, V = .209], psychiatrists [Χ
2 
(5, N = 1,817) = 96.26, p < 
.0005, V = .230], and other physicians [Χ
2 
(5, N = 1,817) = 23.35, p < .0005, V = .113] typically 
made diagnoses in their work settings.  In the USA and Latin America, for example, respondents 
indicated that psychologists very frequently made diagnoses (USA = 99.0%; Latin America 
unweighted = 93.1%, weighted = 92.1%), while psychiatrists (USA = 34.0%; Latin America 
unweighted =  38.6%, weighted = 43.7%) were less commonly reported as being diagnosticians 
in the settings in which respondents worked.  By contrast, respondents in Europe and Asia 
reported that, in the setting where they worked, psychologists (Europe unweighted = 70.2%, 
weighted = 73.2%; Asia unweighted = 86.7%, weighted = 80.1%) and psychiatrists (Europe 
unweighted = 66.3%, weighted = 66.8%; Asia unweighted = 59.3%, weighted = 69.5%) both 
frequently made diagnoses.  Further details of the differences among regions and countries can 
be seen in Table 2.  No significant regional differences were found relating to nurses or other 
professionals, and ICD-10 users were not significantly different from DSM-IV users. 
Regarding psychologists’ diagnostic roles, a modest majority (57.4%; 61.4% weighted) 
reported that they “make diagnoses independently,” compared to 32.1% (31.7% weighted) who 
“contribute to diagnostic formulations made by other health professionals.”  Only 6.4% (3.5% 
weighted) had no role, and 4.1% (3.4% weighted) selected “other.”  Although the majorities in 
all regions reported independently making diagnoses, there were significant differences across 
regions, Χ
2 
(5, N = 1,817) = 132.30, p < .0005, V = .156.  As shown in Table 2, the practice of 
contributing to diagnostic formulations made by other professionals was found to be more 
common among respondents from European (36.9%; 41.1% weighted) and Eastern 
   23 
Mediterranean (37.5%, 31.5% weighted) nations than among those from the USA (3.0%), Africa, 
(18.9%; 19.8% weighted) Latin America (17.8%; 20.0% weighted), and Asia (22.1%; 33.9% 
weighted).  No significant differences were found relating to DCS. 
 
Table 2:  Respondents’ Diagnostic Practices by Region and Country  
     
Who makes diagnoses in the setting 
where you work? (%)   
Respondents’ diagnostic role (%) 
 % 
Always / 
often 
use DCS 
 
DCS used 
most often (%) 
   
Item  
N  
Psychol-
ogists 
Psychia-
trists 
Other 
physicians 
Nurses   
Diagnose 
independently 
Contribute  
to diagnostic 
formulations 
No 
active 
role 
  
ICD- 
10 
DSM- 
IV 
AFRICA 
                
 
Namibia 
 
6 
 
83.3 66.7 16.7 0.0 
 
83.3 16.7 0.0 
 
16.7 
 
0.0 83.3 
 
South Africa 
 
80 
 
93.8 28.8 11.3 5.0 
 
81.3 12.5 3.8 
 
72.5 
 
45.6 49.4 
 
Uganda 
 
18 
 
40.0 50.0 15.0 5.0 
 
50.0 50.0 0.0 
 
72.2 
 
7.7 69.2 
 
Zimbabwe 
 
2 
 
100.0 0.0 0.0 0.0 
 
100.0 0.0 0.0 
 
100.0 
 
100.0 100.0 
 
Unweighted total 
 
106 
 
84.9 34.9 12.3 4.7 
 
76.4 18.9 2.8 
 
69.8 
 
37.0 55.0 
 
Weighted M 
 
26.5 
 
79.3 36.4 10.7 2.5 
 
78.6 19.8 0.9 
 
65.3 
 
38.3 75.5 
ASIA 
                
 
Hong Kong 
 
64 
 
87.5 45.3 20.3 1.6 
 
79.7 17.2 3.1 
 
79.7 
 
3.1 96.9 
 
India 
 
41 
 
90.2 75.6 14.6 0.0 
 
73.2 22.0 0.0 
 
78.0 
 
75.0 12.5 
 
Sri Lanka 
 
8 
 
62.5 87.5 50.0 0.0 
 
25.0 62.5 0.0 
 
12.5 
 
37.5 62.5 
 
Unweighted total 
 
113 
 
86.7 59.3 20.4 0.9 
 
73.5 22.1 1.8 
 
74.3 
 
31.3 64.3 
 
Weighted M 
 
37.7 
 
80.1 69.5 28.3 0.5 
 
59.3 33.9 1.0 
 
56.7 
 
38.5 57.3 
EASTERN MEDITERRANEAN 
            
 
Israel 
 
25 
 
96.0 40.0 8.0 0.0 
 
76.0 20.0 4.0 
 
24.0 
 
9.2 85.0 
 
Lebanon 
 
9 
 
88.9 55.6 0.0 0.0 
 
66.7 33.3 0.0 
 
77.8 
 
11.1 77.8 
 
Turkey 
 
126 
 
64.3 67.5 9.5 0.8 
 
46.8 41.3 9.5 
 
54.0 
 
7.4 87.6 
 
Unweighted total 
 
160 
 
70.6 62.5 8.8 0.6 
 
52.5 37.5 8.1 
 
50.6 
 
9.2 85.0 
 
Weighted M 
 
53.3 
 
83.1 54.3 5.8 0.3 
 
63.2 31.5 4.5 
 
51.9 
 
12.0 79.8 
EUROPE 
                
 
Denmark 
 
207 
 
57.5 73.4 7.2 5.3 
 
37.2 51.2 4.3 
 
71.0 
 
94.0 3.5 
 
Estonia 
 
9 
 
55.6 88.9 33.3 0.0 
 
0.0 100.0 0.0 
 
55.6 
 
100.0 0.0 
 
Finland 
 
172 
 
11.0 79.7 28.5 1.7 
 
3.5 72.1 18.0 
 
19.8 
 
76.3 21.1 
 
France 
 
285 
 
68.1 67.0 36.8 3.9 
 
34.0 44.2 15.1 
 
22.8 
 
19.2 69.5 
 
Germany 
 
147 
 
98.6 21.8 12.2 0.7 
 
93.9 4.8 0.7 
 
93.2 
 
93.2 5.4 
 
Ireland 
 
33 
 
84.8 48.5 6.1 3.0 
 
48.5 42.4 6.1 
 
69.7 
 
6.1 90.9 
 
Norway 
 
220 
 
99.1 75.9 19.1 6.4 
 
87.7 8.6 1.4 
 
86.4 
 
98.2 1.4 
 
Sweden 
 
89 
 
87.6 69.7 31.5 13.5 
 
56.2 31.5 6.7 
 
71.9 
 
34.1 61.4 
 
Switzerland 
 
32 
 
100.0 59.4 9.4 0.0 
 
96.9 3.1 0.0 
 
78.1 
 
71.0 19.4 
 
UK 
 
43 
 
69.8 83.7 16.3 11.6 
 
41.9 53.5 0.0 
 
34.9 
 
36.6 61.0 
 
Unweighted total 
 
1237 
 
70.2 66.3 22.0 4.7 
 
50.6 36.9 7.7 
 
57.0 
 
68.4 27.6 
 
Weighted M 
 
123.7 
 
73.2 66.8 20.0 4.6 
 
50.0 41.1 5.2 
 
60.3 
 
62.9 33.3 
LATIN AMERICA 
                
 
Argentina 
 
21 
 
90.5 52.4 19.0 0.0 
 
57.1 23.8 4.8 
 
61.9 
 
0.0 85.7 
 
Mexico 
 
80 
 
93.8 35.0 27.5 1.3 
 
76.3 16.3 2.5 
 
51.3 
 
10.8 81.1 
 
Unweighted total 
 
101 
 
93.1 38.6 25.7 1.0 
 
72.3 17.8 3.0 
 
53.5 
 
8.4 82.1 
 
Weighted M 
 
50.5 
 
92.1 43.7 23.3 0.6 
 
66.7 20.0 3.6 
 
56.6 
 
5.4 83.4 
USA 
                
 
USA 
 
100 
 
99.0 34.0 15.0 3.0 
 
96.0 3.0 0.0 
 
86.0 
 
1.0 93.9 
OVERALL 
                
 
Unweighted total 
 
1817 
 
75.0 60.4 20.0 3.8 
 
57.4 32.1 6.4 
 
59.7 
 
51.4 43.8 
 
Weighted M 
 
116 
 
79.9 56.0 17.7 2.4 
 
62.2 30.6 3.6 
 
60.2 
 
37.7 59.6 
Note.  Table does not display percentages of respondents who selected “other” in response to  “Who makes diagnoses…?”, or who selected “ICD-9” or 
“other” as the DCS used most often.  Item N refers to the number of participants who responded to the majority of these items. 
 
   24 
Usage of diagnostic classification systems.  Respondents were asked, “As part of your 
day-to-day clinical work, how much of the time do you use a formal DCS, such as the ICD-10, 
the DSM-IV, the ICD-9 or ICD-9-CM, or a national classification?”  Responses from the overall 
sample followed a clear trend, such that the majority reported using a DCS with high frequency: 
35.7% (34.7% weighted) reported using a DCS “always or almost always, 24.0% (25.7% 
weighted) used one “often,” 18.1% (22.2% weighted) “sometimes,” 16.1% (14.4% weighted) 
“rarely,” and 6.1% (3.0 % weighted) “never”.  Distinct variations were found among respondents 
from different regions, Χ
2 
(20, N = 1,817) = 114.96, p < .0005, V = .126, and between ICD-10 
and DSM-IV users, Χ
2 
(3, N = 1,611) = 53.58, p < .0005, V = .182.  Whereas a large majority of 
the respondents from the USA (86.0%) reported “always” or “often” using a DCS, this majority 
was much smaller among those from the Eastern Mediterranean (50.6%; 51.9% weighted), Latin 
America (53.5%; 56.5% weighted), and Europe (57.0%; 60.3% weighted).  Further, among 
respondents who used any DCS, those who used the ICD-10 tended to use it more frequently 
(71.8% always/often) than those who used the DSM-IV (56.5% always/often). 
 With regard to particular DCSs, 51.4% (36.8% weighted) of all respondents indicated 
that they most often use the ICD-10, followed by the DSM-IV (43.8%; 56.8% weighted), “other” 
(4.1%; 5.7% weighted), and ICD-9 (0.7%).  There was a great deal of regional variability related 
to participants’ usage of the ICD-10 or DSM-IV, Χ
2 
(5, N = 1,611) = 445.49, p < .0005, V = .526.  
Majorities of respondents in European nations (68.4%; 62.9% weighted) indicated that they use 
the ICD-10 most often.  By contrast, in the USA (93.9%) and Latin America (82.1%; 83.4% 
weighted), large majorities indicated that they use the DSM-IV, and smaller majorities followed 
this trend leaning toward the DSM-IV in all other regions.  Because this investigation was 
conducted as part of the ICD revision process, respondents’ level of familiarity with the ICD-10 
was of interest.  Among clinicians who use a DCS other than the ICD-10, 36.2% (44.3% 
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weighted) were at least Somewhat familiar with the ICD-10.  No significant regional differences 
were found on this item. 
General Features of Diagnostic Classification Systems 
 Most important purpose.  Participants were asked, “From your perspective, which is the 
single most important purpose of a diagnostic classification system?”  As presented in Figure 1, 
the three most popular responses were clinical purposes—(a) treatment and management, (b) 
inter-clinician communication, and (c) communication with patients—which together comprised 
a large majority of  the sample’s response (87.6%; 89.1% weighted).  Significant differences 
were found across regions, Χ
2 
(25, N = 1,883) = 106.87, p < .0005, V = .107, the most notable 
difference being that respondents from Latin America most often selected inter-clinician 
communication (48.3%; 48.2% weighted) as the most important purpose, while only 16.8% 
(14.9% weighted) of the sample selected treatment and management decisions.  No significant 
differences were between ICD-10 and DSM-IV users.   
 
Figure 1.  Respondents’ views on “what is the single, most important purpose of diagnostic classification system.”  Percentages are 
equally weighted by country.  Unweighted percentages were relatively similar (from left to right: 38.7%, 15.5%, 33.4%, 3.3%, 4.6%, 
and 4.5%).   
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 Optimal number of diagnostic categories.  Respondents were asked, “In clinical 
settings, how many diagnostic categories should a classification system contain to be most useful 
for mental health professionals?”  The vast majority (85.1%; 86.9% weighted) indicated that a 
DCS would be most useful if it contained between 10 and 100 categories.  Specifically, 34.8% 
(38.3% weighted) selected 10-31 categories, and 50.3% (48.6% weighted) selected 31-100 
categories as the optimal number.  Only 10.6% (9.0% weighted) selected 101-200, and 4.4% 
(4.1% weighted) selected more than 200 as the preferred number of categories.  No significant 
variations were found across regions or DCS.   
 Strict criteria vs. flexible guidance.  In a DCS, diagnostic categories can be defined 
according to strict, specified diagnostic criteria or more flexible diagnostic guidelines.  When 
asked which format would allow for “maximum utility in clinical settings,” the large majority, 
78.3% (74.8% weighted), preferred “diagnostic guidance that is flexible enough to allow for 
cultural variation and clinical judgment” over “clear and strict (specified) diagnostic criteria for 
all disorders” (21.7%; 25.2% weighted).  Moreover, this result was not significantly different 
across regions or users of different DCSs (see Figure 2). 
 
 
Figure 2.  For maximum clinical utility, clinicians preferred “diagnostic guidance that is flexible enough to allow for cultural variation 
and clinical judgment” over “clear and strict (specified) diagnostic criteria for all disorders.”   
   27 
 Severity.  When respondents were asked what would be the best way to incorporate the 
concept of severity in the diagnostic system, there was very little consensus beyond the general 
agreement that it should be included somehow (88.1%; 89.8% weighted).  That is, as Figure 3 
illustrates, these respondents were nearly evenly split into three different opinions as to how best 
to incorporate considerations of severity: (a) subtypes based on severity and/or symptom count 
(29.7%; 32.4% weighted); (b) subtypes based on degree of functional impairment (29.5%; 31.9% 
weighted); or (c) on a separate, “cross-cutting” axis used for all diagnoses (28.9; 25.5% 
weighted; see Figure 3).  Although there were some statistically significant differences by 
region, Χ
2 
(15, N = 1,808) = 58.10, p < .0005, V = .104, no clear trends emerged.  Rather, all 
regional groups selected the same three responses most frequently, and in no case did a majority 
(i.e., > 50%) select any one response.  No significant differences were found for DCS. 
 Functional impairment.  Similar to the above item on severity, respondents were asked 
whether and how considerations of functional status should be conceptualized in a DCS.  As 
shown in Figure 3, 76.9% (81.6% weighted) of participants provided responses indicating that it 
should be included somehow—most commonly (48.2 %; 46.8% weighted), that “functional 
status should be a diagnostic criterion for some disorders” when necessary.  Following this 
response, 28.7% (34.9% weighted) responded, “functional impairment should be a diagnostic 
criterion for most disorders,” and the rest (23.1%; 18.4% weighted) indicated that “functional 
status should not be included in diagnostic criteria.”  No significant regional or DCS-related 
differences were found.  
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Figure 3.  Clinicians’ views on “the best way for a diagnostic system to address the concept of severity.”   
 
 
 
 
Figure 4.  Clinicians’ opinions on “the best way for a diagnostic system to conceptualize the relationship between diagnosis and 
functional status.”   
 
 
 
 
Figure 5.  Clinicians’ views on whether to incorporate a dimensional component into a diagnostic classification system and why.  
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 Dimensional component.  As Figure 5 illustrates, when asked whether a DCS should 
include a dimensional component, the majority of participants (78.9%; 83.2% weighted) 
responded in favor of dimensional classification: 47.7% (49.1% weighted) because it would 
provide a more accurate representation of psychopathology, and 31.2% (34.1% weighted) 
because it would offer more detailed and personalized assessment.  Among those who did not 
desire a dimensional classification, their rationale was nearly evenly split between it being too 
complicated for clinical settings (11.9%; 9.6%) and insufficient research evidence to support its 
reliability (9.1%; 7.2% weighted).  Significant differences were found among regions, Χ
2 
(115, N 
= 1,716) = 55.79, p < .0005, V = .104, but the differences were not related to whether or not 
respondents endorsed dimensional classification, but rather to the justification they selected to 
support their answer.  No significant differences were found relating to DCS. 
 Depression and proportionality to adverse life events.  Of particular relevance for the 
ICD revision process is the question of whether a diagnosis of depression should be “assigned if 
the symptoms are a proportionate response to adverse life events.”  Among the overall sample, 
and consistently across different regions and DCSs, respondents were almost perfectly divided 
on this questions: 51.2% (52.0% weighted) selected “Yes, if the full depressive syndrome is 
present, the diagnosis of depression should be made regardless of whether there are life events 
that can potentially explain it;" 48.8% (48.0% weighted) disagreed, responding “No, a 
proportionate response to an adverse life event should not be considered a mental disorder.” 
Cultural Concerns 
 Cross-cultural applicability.  Respondents who reported that they were currently seeing 
patients and that they used a diagnostic system at least “rarely” were asked: “Please rate the 
extent to which you agree with the following statement based on your day to day clinical 
experience: ‘The diagnostic system I use is difficult to apply across cultures, or when the 
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patient/service user is of a different cultural or ethnic background from my own.’”  Among all 
participants, 5.4% (6.1% weighted) completely agreed, 25.4% (29.1% weighted) mostly agreed, 
51.9% (50.2% weighted) agreed somewhat, and 17.3% (15.9% weighted) did not agree with the 
above statement.  As Figure 6 demonstrates, there were significant differences among regions, Χ
2 
(15, N = 1,513) = 43.68, p < .0005, V = .098, such that respondents from the Eastern 
Mediterranean (35.0%; 38.5% weighted), Latin America (33.7%; 32.1% weighted), Europe 
(32.4%; 30.8% weighted), and Africa (29.0%l 43.2% weighted) more often indicated that they 
mostly or completely agreed that their DCS was cross-culturally problematic, compared to those 
from the USA (18.4%) and Asia (20.0%; 33.4% weighted).  No significant differences were 
found for DCS.  
 U.S. and European Bias.  Respondents were also asked to indicate their level of 
“agreement with the following statement based on your day to day clinical experience: ‘The 
diagnostic system I use is problematic because it is over-embedded in U.S. and European 
culturally-derived concepts and values.’”  Results followed a similar trend as for the previous 
item: 6.2% (7.2% weighted) selected “completely agree,” 23.5% (29.1% weighted) “mostly 
agree,” 48.7% (42.3% weighted) “Agree somewhat,” and 21.6% (21.4% weighted 
 “Do not agree”.  Figure 6 also illustrates significant regional differences for this item, Χ
2 
(15 N = 
1,512) = 45.91, p < .0005, V = .101.  Specifically, respondents from Africa, the Eastern 
Mediterranean, and Latin America (38.0 – 44.6%; 46.0 – 47.7% weighted) more often “mostly” 
or “completely” agreed that U.S./European bias was a problem, compared to relatively fewer in 
Asia, the USA, and Europe (21.8 – 27.8% unweighted; 21.8 – 37.4% weighted).  No significant 
differences were found relating to DCS. 
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Figure 6.  Percentages of respondents in each national subsample who indicated that they “mostly agree” or “completely agree” with 
the above statements about diagnostic classification systems’ cross-cultural problems and U.S./European bias.  Data from the 
Zimbabwean sample are not presented due to very low response on these items (N < 3). 
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 Stigmatizing terminology.  When asked whether “any of the terms used in current 
diagnostic systems are stigmatizing in your language or cultural context,” over one-third of the 
entire sample (36.5%; 37.1% weighted) responded “yes”.  As presented in Figure 7, this finding 
varied significantly across regional groups, Χ
2 
(5, N = 1,551) = 38.92, p < .0005, V = .158.  
Interestingly, the highest percentages of agreement came from respondents in Europe (41.7%; 
38.7% weighted) followed by the USA (32.2%) and Eastern Mediterranean (28.9%; 43.9% 
weighted); whereas the rest of the samples indicated rates of agreement between 22.9% and 
25.0% (24.9 – 38.7% weighted).  No significant differences were found by DCS.   
 Need for a national classification system.  Overall, 18.3% (28.0% weighted) responded 
“yes” to the question, “Do you see a need in your country for a national classification of mental 
disorders (i.e., a country-specific classification that is not just a translation of ICD-10)?”  As 
Figure 7 illustrates, there was a great deal of variability among subsamples on this item; 
significant differences were found for region, Χ
2 
(5, N = 1,575) = 229.05, p < .0005, V = .381, 
and DCS, Χ
2 
(1, N = 1,321) = 71.68, p < .0005, V = .233.  A slight majority of respondents from 
Latin America (51.3%; 53.0% weighted) indicated that there was a need for a national DCS, as 
did many respondents from Africa (42.9%; 63.4% weighted), the Eastern Mediterranean (42.7%; 
35.2% weighted), and, to a lesser extent, Asia (24.8%; 30.5% weighted).  By contrast, European 
(9.7%; 7.6% weighted) and American (10.5%) respondents less often indicated such a need.  
Furthermore, out of all the respondents who reported that they used the DSM-IV most frequently, 
26.5% indicated a need for a national classification in their country, compared to only 9.0% of 
ICD-10 users who selected this response.   
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Figure 7.  Percentages of respondents in each national subsample who responded “yes” to the above statements about stigma and 
the need for a national classification system.  Data from the Zimbabwean sample are not presented due to very low response on 
these items (N < 3). 
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 Meeting the needs of different users and stakeholders.  Because DCSs are used by a 
variety of professionals and nonprofessionals for diverse purposes, one concern for the current 
ICD revision process is how best to accommodate those users.  Accordingly, respondents were 
asked whether primary care providers should have a modified/simpler version or the same DCS 
as mental health professionals. Overall, a slight majority (53.9%; 58.4% weighted) favored a 
modified version for primary care.  Although ICD-10 and DSM-IV users were not significantly 
different on this item, there were significant variations across regions, Χ
2 
(5, N = 1,810) = 32.44, 
p < .0005, V = .134, as seen in Figure 7.  Greater proportions of respondents from the Eastern 
Mediterranean (72.4%; 65.2% weighted), Asia (64.4%; 75.6% weighted), and Africa (54.1%; 
70.6% weighted) favored a simpler primary care version than did those from the USA (45.5%), 
Europe (51.2%; 49.3% weighted), and Latin America (53.3%; 49.7% weighted). 
 Overall, 84.8% (87.8% weighted) of respondents indicated that they “completely” or 
“mostly” agree with the following statement: “A diagnostic classification system should serve as 
a useful reference not only for psychiatrists but for all mental health professionals (e.g., 
psychologists, social workers, psychiatric nurses).”  Out of the remainder, 11.0% (9.0% 
weighted) selected “agree somewhat” and 4.2% (3.2% weighted) “do not agree.” “In response to 
a similar item, 70.6% (74.7% weighted) of the entire sample indicated that they “completely” or 
“mostly” agreed that “A diagnostic classification system should be understandable to service 
users, patient advocates, administrators, and other relevant people as well as to health 
professionals.”  Fewer respondents selected “agree somewhat” (23.0%; 19.7% weighted) and “do 
not agree.”  After “completely” and “mostly” agree responses were collapsed on these two items, 
no significant differences were found for region or DCS. 
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Usage and Evaluation of ICD-10 and DSM-IV Diagnostic Categories  
 Usage of diagnostic categories.  Respondents who reported that they regularly see 
patients and use either the ICD-10 (N = 797) or the DSM-IV (N = 629) were asked a series of 
questions about specific diagnostic categories.  First, they were asked to select from either a list 
of 44 ICD-10 diagnostic categories or a list of 45 DSM-IV diagnostic categories (depending on 
which DCS they used) which ones “you use once a week or more in your day-to-day clinical 
practice (that is, you see a patient or client with that diagnosis at least once a week), whether or 
not you personally assign the diagnosis.”  Second, participants were asked to evaluate those 
particular categories they selected.  Because the conditional administration of these three items 
(frequency of use, ease of use, and goodness of fit) was not reliably implemented in the paper-
and-pencil version of this survey, responses from participants in the Ugandan sample who 
attempted to complete these items (N = 2) were excluded from these analyses. 
 
Figure 8.  Percentages of clinicians who reported seeing persons with select ICD-10 diagnostic categories at least once a week.  
Bars represent mean percentages across all national subsamples, with each country weighted equally.  Lines represent the 
unweighted total percentages of the entire sample.  MBDs = mental and behavioural disorders.   
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Figure 9.  Percentages of clinicians who reported seeing persons with select DSM-IV diagnostic categories at least once a week.  
Bars represent mean percentages across all national subsamples, with each country weighted equally.  Lines represent the 
unweighted total percentages of the entire sample.  
 
 
 
Figures 8 and 9 present the percentages of clinicians who reported that they regularly use 
particular diagnostic categories from the ICD-10 and DSM-IV, respectively.  Patterns of 
frequency were generally similar between ICD-10 and DSM-IV users and categories.  Mood and 
anxiety disorders were by far the most commonly seen categories, and stress-related and 
childhood disorders were also seen fairly regularly.  Less frequently seen were substance-related 
disorders, psychotic disorders, and eating disorders.  Interestingly, individual clinicians saw an 
average of only 8.85 categories (SD = 5.69; weighted M = 9.77) on a regular basis, with no 
significant difference between ICD-10 users and DSM-IV users.  However, as Figure 10 
illustrates, the number of categories seen regularly varies by country and region.  Regional usage 
ranged from a mean of 6.91 (SD = 4.17; weighted M = 6.59) diagnostic categories in Latin 
America to 10.58 (SD = 5.63; weighted M = 10.58) in the USA.  But the variability was most 
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notable at the country level, ranging from means of 6.07 (SD = 4.92) categories in Argentina and 
6.19 (SD = 4.12) in Hong Kong to 14.41 (SD = 6.57) in India. 
 
Figure 10.  Average number of diagnostic categories (ICD-10 or DSM-IV) that clinicians see at least once a week, by country.  
Ugandan and Zimbabwean samples are not presented due to very small sample sizes on this item (N < 3).  
 
 
 Ease of use and goodness of fit of diagnostic categories.  Next, participants were 
presented with the following item: 
Please evaluate the ICD-10 [or DSM-IV] diagnostic categories you previously selected 
by making a rating of each category on two dimensions: 1) ease of use of the ICD-10 
[DSM-IV] diagnostic criteria for that category or group of disorders; and 2) goodness of 
fit or accuracy of the ICD-10 [DSM-IV] definition, description, and diagnostic criteria in 
describing the patients or clients you see in clinical practice. 
Note that respondents were asked to rate only those categories that they had already reported 
they encountered regularly in clinical practice.  This method was selected in order to ensure that 
clinicians’ evaluations were informed by clinical experience with patients with those particular 
diagnoses.  Ease of use and goodness of fit ratings were originally made on the following 4-point 
likert scale: 0 = Not at all (easy to use or accurate); 1 = Somewhat; 2 = Quite; and 3 = Extremely.  
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In order to facilitate comparisons between the results on these two items and across all 
categories, the original 0-3 likert scale variables were transformed into continuous variables on a 
scale of 0-1.  Thus, the above descriptions of ratings 0, 1, 2, and 3 on the original scale can be 
interpreted at 0.00, 0.33, 0.67, and 1.00, respectively, on the transformed scale. 
Ratings of ease of use and goodness of fit are presented in Figure 11 for ICD-10 
categories and in Figure 12 for DSM-IV categories.  The overall mean ratings were relatively 
favorable for diagnostic categories in both the ICD-10 (M = .641, SD = .076 for ease of use; M = 
.600, SD = .072 for goodness of fit) and the DSM-IV (M = .657, SD = .076; M = .597, SD = 
.075), with no significant differences between the two DCSs.  Interestingly, mean ease of use 
ratings were nearly always greater than goodness of fit ratings, and participants’ individual ease 
of use and goodness of fit ratings were highly, though not perfectly, correlated (for ICD-10 
categories, M Pearson’s r = .662, SD = .105; for DSM-IV categories, M Pearson’s r = .680, SD = 
.101).  Table 3 lists ICD-10 and DSM-IV categories with particularly low mean ratings for ease 
of use and goodness of fit, defined as falling at least one half standard deviation below the mean.  
 
Table 3:  ICD-10 and DSM-IV Diagnostic Categories with Low Ease of Use and/or Goodness of Fit. 
ICD-10 Categories EOU GOF 
 
DSM-IV Categories EOU GOF 
Adjustment disorder .603 .550 
 
Asperger's Disorder .557 .477 
Antisocial personality disorder .609 .547 
 
Autistic Disorder .608 .541 
Asperger's syndrome  .495 .451 
 
Bipolar II Disorder .577 .534 
Bipolar affective disorder .596 .570 
 
Borderline Personality Disorder .629 .535 
Borderline personality disorder  .556 .514 
 
Brief Psychotic Disorder .602 .550 
Delirium, not substance-induced .583 .583 
 
Delusional Disorder .615 .615 
Dissociative [conversion] disorders .497 .447 
 
Dissociative Disorders .483 .454 
Habit and impulse disorders .591 .554 
 
Impulse Control Disorders .500 .483 
Hyperkinetic (attention deficit) disorder .556 .500 
 
Primary Sleep Disorders .576 .510 
MBDs due to the use of hallucinogens .595 .524 
 
Schizoaffective Disorder .544 .489 
MBDs due to the use of volatile solvents .583 .583 
 
Schizotypal Personality Disorder .538 .441 
Mixed anxiety and depressive disorder .599 .560 
 
Sexual Dysfunctions .603 .559 
Schizoaffective disorder .508 .508 
 
Somatoform Disorders .564 .474 
Schizotypal disorder .510 .525 
 
Tic disorders .593 .531 
Somatoform disorders .523 .510 
 
Vascular Dementia .603 .564 
Vascular dementia .650 .533 
 
   
Note.  EOU = ease of use; GOF = goodness of fit; MBDs = mental and behavioural disorders.  Categories are considered to have a 
low ease of use or goodness of fit if the mean rating fell at least one-half standard deviation below the mean for all categories.  
Boldface type denotes these low ratings.  All mean ratings are unweighted. 
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Figure 11.  Clinicians’ unweighted mean ratings for the ease of use and goodness of fit of the ICD-10 diagnostic categories they see 
regularly.  Categories are in order from most to least frequently seen, such that those toward the left of the graph were seen more 
often and therefore received more ratings than those near the right.  This warrants cautious interpretation, particularly toward the 
data points toward the right side of the graph. MBDs = mental and behavioural disorders.   
 
 
 
Figure 12.  Clinicians’ unweighted mean ratings for the ease of use and goodness of fit of the DSM-IV diagnostic categories they 
see regularly.  Categories are in order from most to least frequently seen, such that those toward the left of the graph were seen 
more often and therefore received more ratings than those near the right.  This warrants cautious interpretation, particularly toward 
the data points toward the right side of the graph.  
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 Problematic diagnostic categories.  Approximately half (49.4%; 53.1% weighted) of all 
respondents indicated that there are “diagnostic categories with which you are especially 
dissatisfied, or that you believe are especially problematic in terms of their goodness of fit in 
clinical settings.”  There was significant variability across regions, Χ
2 
(4, N = 1,594) = 25.07, p < 
.0005, V = .125, such that rates of dissatisfaction were 33.3% (37.9 weighted) in Latin America, 
40.6% (55.6% weighted) in Africa, 42.9% (63.7% weighted) in Eastern Mediterranean, 46.3% 
(48.5% weighted) in Asia, 52.1% (51.5% weighted) in Africa, and 60.2% (60.2% weighted) in 
the USA.  No significant differences were found for DCS.   
 Adding, moving, and removing diagnostic categories.  Lastly, in two items, 
participants were asked whether there any specific diagnostic categories that you feel should be: 
(a) “removed or moved to another section?” or (b) “added to the classification system for mental 
disorders?”  The majority of respondents in both cases responded “No.”  Interestingly, a greater 
percentage felt that disorders should be added (32.7%; 35.8% weighted) than moved/removed 
(22.3%; 22.9% weighted).  ICD-10 users more often reported that disorders should be added 
(38.6%) compared to DSM-IV users (28.0%), Χ
2 
(1, N = 1,280) = 16.16, p < .05, V = .112.  No 
other significant differences were found for region or DCS. 
Discussion  
The primary aims of this study were to examine practicing psychologists’ views on 
conceptual and practical issues concerning the clinical utility of DCSs, so as to inform the 
ongoing development of the ICD-11.  In this effort, particular attention was paid to whether there 
were any significant differences among clinicians from different nations, global regions, or 
between ICD-10 and DSM-IV users.  Indeed, the size, diversity, and characteristics of the 
obtained samples were sufficient to allow for an examination of these questions.  With over 93% 
of the sample currently seeing patients and an average of nearly 14 years of clinical experience, 
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participants collectively represented a great deal of clinical experience with patients with mental 
health conditions.  Furthermore, despite differences in national sample sizes and regional 
representation, relatively large numbers of participants were obtained from each of the global 
regions examined, allowing for preliminary examinations of regional and DCS-related 
differences.   
Among some of the more consistent findings were that clinicians generally emphasized 
the priority of clinical utility as the principal purpose of and primary consideration when revising 
a DCS.  Respondents agreed that a DCS should somehow incorporate dimensional classification, 
severity, functional impairment, and flexible diagnostic guidelines, but responses also reflected 
the current disagreement regarding how to make these kinds of broad, cross-cutting revisions.  
Results generally suggested favorable views on particular diagnostic categories and cultural 
concerns, while also indicating specific areas for improvement.  Concerning the secondary aim 
of this investigation, many (but not all) of these findings were associated with significant 
regional differences; fewer were associated with differences between ICD-10 and DSM-IV users.  
These main findings and variations among subsamples are discussed below in greater detail. 
Professional Practices of Psychologists around the Globe 
 Although not a primary objective, this study offered interesting findings regarding the 
professional practices of psychologists with respect to assessment, diagnosis, and usage of a 
DCS (see Table 2).  Given that these results were so variable within regions, they may be more 
accurately understood at the country rather than regional level.  Internationally, individual 
psychologists appear to play a large and, for the most part, independent role in providing 
assessments and diagnoses for persons with mental health problems.  This, however, was not the 
case in some countries, particularly in several Western European nations (e.g., Finland, France, 
Denmark, United Kingdom), where psychologists more often reported that they contributed to 
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the diagnostic formulations made by other professionals.  The findings for these countries may 
be reflective of their health systems, where mental health care providers are often integrated into 
the healthcare system and work in medical settings, as opposed to separate independent or group 
private mental health practices (European Observatory on Health Systems and Policies, 2012). 
 While the majority of psychologists appear to use a DCS with some regularity in their 
clinical practice, a significant number of participants do not use a DCS at all, or only do so 
occasionally.  Results suggest that DCS usage is highest (> 75% often/always use a DCS) among 
psychologists in the United States, Germany, Norway, Hong Kong, Switzerland, India, and 
Lebanon; and lowest (< 25% often/always use) among those in Finland, France, and Israel. With 
regard to the usage of particular DCSs, it should be noted that this study was conducted for the 
purposes of the ICD-11 revisions, and not to draw comparisons between the ICD and DSM.  
Nevertheless, results offer evidence that both systems are in widespread use by psychologists 
around the world.  Broadly speaking, the ICD-10 appears to be more commonly used by 
psychologists in most European nations, while the DSM-IV is used by the majority of clinicians 
in most other nations represented in this study.  However, there was considerable variability 
across countries, even among those in the same region.  Further, open-ended responses indicated 
that that it is not uncommon for both systems to be used together. 
 Many of the above differences in diagnostic practices among countries and regions are 
likely related to differences in healthcare systems and the definitions, training, and roles of a 
psychologist within different countries.  For example, ICD diagnostic codes are a prerequisite for 
public or private health care reimbursement in some countries (e.g., United States; Reed, 2010), 
but may be less essential for the provision of care in other countries such as France, where 
research has consistently found lower rates of DCS usage among clinicians (Reed et al., 2011; 
Sechter, 1995).  Regardless of the particularities of national healthcare policies, ICD codes (not 
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DSM codes) are required by all WHO member nations for the reporting of international health 
statistics (Reed, 2010).  Thus, it is not surprising that, among those who used a DCS, the ICD-10 
was used with greater frequency than the DSM-IV.  That is, DCS usage may be compulsory 
among many ICD users, but discretionary among many DSM users.  Relatedly, DSM-IV usage 
has been found to be associated with research and training while ICD-10 usage is more common 
among clinicians (Mezzich, 2002). 
 Several other aspects of international psychology warrant attention prior to any further 
interpretation of the results (see Stevens and Wedding, 2004).  To begin with, the very definition 
of “psychologist” varies greatly across countries, from exclusively Ph.D.- or Psy.D.-holding, 
licensed clinicians in the United States to primarily bachelor’s- and master’s-level psychologists 
in most other countries, especially developing nations.  Moreover, there is sometimes little or no 
distinction between the roles of counseling and clinical psychologists.  Associated with these 
differences are differences in training (e.g., quality and length of training; knowledge of 
psychopathology, assessment, and diagnosis; accreditation standards) as well as standards for 
licensure and conventions of practice (e.g., independent practice or supervision by physicians; 
relative status, practice, and availability of pharmacotherapy versus psychotherapy).  There is 
also considerable variability in the degree to which psychology has been established, recognized, 
regulated, and organized as a profession within different countries (Stevens & Wedding, 2004).  
In light of this heterogeneity among psychologists in the countries represented in the present 
study, national and regional differences may be reflective of differences in the nature of 
professional psychology (e.g., training, practice, regulation, roles), healthcare policy, and cultural 
factors, as well as participants’ individual opinions. 
 It should also be noted that the present findings on psychologists’ diagnostic and 
professional practices differed considerably from those of psychiatrists in the WPA-WHO survey 
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(Reed et al., 2011).  Compared to data on psychiatrists, psychologists reported spending fewer 
hours in contact with patients; seeing fewer diagnostic categories per week; using DCSs less 
frequently overall, and with a greater range of variability internationally; and using the ICD-10 
less often and the DSM-IV more often.  These differences can likely be explained by professional 
differences in clinical training and practice.  First, whereas psychologists often provide 
psychotherapy, psychiatrists tend to spend more time delivering pharmacotherapy (Mojtabai & 
Olfson, 2008; Phelps, Eisman, & Kohout, 1998; Pingitore, Scheffler, Sentell, & West, 2002).  
Thus, for any given patient, psychologists may spend more time—in terms of both the duration 
and frequency of appointments—engaged in planning and delivering treatments.  This would 
result in fewer clients, and thus, fewer disorders seen on a weekly basis.  Second, psychologists 
in the present sample include a range of practicing professional psychologists, which may 
include clinical, counseling, health, child, school, or other areas of psychology.  Psychologists as 
a group are therefore likely to perform a range of services with diverse populations and issues, 
many of which may be non-psychiatric in nature.  This, too, limits the number of disorders seen 
regularly by psychologists and suggests that their clinical experiences may be quite different 
from those of psychiatrists. 
 Third, compared to psychiatrists, psychologists may be more likely to engage in 
professional activities that do not involve direct patient contact (e.g., consultation, billing, report 
writing, supervision, treatment planning), thereby reducing the proportion of their time that is 
spent with patients.  Fourth, psychologists’ relatively low rates of DCS usage, as well as their use 
of one manual over another, may be due to a combination of factors such as less extensive 
education and training in DSM- and/or ICD-based diagnostic practices, particularly in developing 
countries (Stevens and Wedding, 2004); fewer policies requiring them to report diagnostic codes, 
or an unawareness of existing policies (Reed, 2010); or philosophical opposition to the practice 
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of diagnosing and classifying persons in terms of mental disorders, as was noted in several of the 
open-ended responses in the present study.  Of course, the present sample and the Reed et al. 
(2011) sample are dissimilar in sample size and countries represented, so comparisons between 
the two should be interpreted with caution.  Nevertheless, differences between professional 
psychology and psychiatry provide a more informed understanding of discrepant results, both in 
regard to professional practices as well as more substantive findings discussed below. 
Views on Diagnostic Classification 
 Results were surprisingly consistent—across regions and DCS, and in line with previous 
research—in regard to global aspects of diagnostic classification.  Consistency, however, should 
not be mistaken for consensus.  That is, distributions of responses were similar across 
subsamples, but there were few cases in which a clear majority preferred one view to another.  
The most notable case of consensus is that, in line with previous research, an overwhelming 
majority (87.6%) of psychologists indicated that the most important purposes of a DCS were 
related to clinical care and communication (i.e., treatment/management decisions, inter-clinician 
communication, and communication with patients), as opposed to all nonclinical and “other” 
purposes, such as billing.  Although this emphasis on clinical utility appears to be common 
across regions, DCS, and professions, findings on this item suggested a substantive difference 
between psychologists in the present study, who emphasized “clinical treatment/management 
decisions” as the top priority, and psychiatrists, who in previous research consistently 
emphasized “communication among clinicians” as foremost (Bell et al., 2008; Mellsop et al., 
2007a, 2007b, 2011; Reed et al., 2011; Suzuki et al., 2010; note, however, that Latin American 
samples of psychologists in the present study did follow this latter trend).  Again, these 
differences may be accounted for by differences between psychological and psychiatric 
approaches to treating mental disorders (Mojtabai & Olfson, 2008; Phelps, Eisman, & Kohout, 
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1998; Pingitore et al., 2002; Wyatt & Livson, 1994).  That is, psychologists delivering 
psychotherapeutic services may be more likely to select and provide services oriented toward a 
particular clinical syndrome; by contrast, psychiatric treatment may be less concerned with 
diagnostic categories and more concerned with ameliorating and monitoring particular symptoms 
and side effects.   
 Across all regions, DCSs, and consistent with findings among psychiatrists (Bell et al., 
2008; Mellsop et al., 2007a, 2007b, 2011; Reed et al., 2011; Suzuki et al., 2010), the vast 
majority of psychologists preferred a DCS with fewer diagnostic categories (i.e., 10-100 
categories), rather than more, and flexible diagnostic guidelines rather than strict criteria.  These 
findings stand in contrast to the DSM-IV and ICD-10, which both contain several hundred 
potential diagnoses arranged in complex hierarchical taxonomies, offering empirical support for 
calls toward nosological simplification (e.g., Flanagan & Blashfield, 2010; Watson & Clark, 
2006).  In particular, these results run counter to the DSM-IV’s method of operationalizing 
diagnoses through symptom checklists and elaborate diagnostic requirements.  Rather, they 
suggest that a more flexible approach, perhaps similar to that of the ICD-10’s guidelines, may be 
preferable.  By contrast, psychologists’ opinions were consistently divided on other broad 
questions about the structure and content of a DCS.  Consistent with previous findings among 
psychiatrists (Reed et al., 2011), majorities of psychologists agreed that functional impairment, 
severity, and dimensional classification should be included in a DCS, but there was little 
agreement as to how or why.  Any differences between regional and DCS groups were 
nonsignificant or of a small effect size, suggesting that the differences of opinion on these items 
are common and widespread, even among clinicians in the same countries and regions.   
 Psychologists’ opinions were also divided on the question of diagnoses and 
proportionality to adverse life events.  However, unlike the conflicting views on functional 
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impairment, severity, and dimensional classification, results on this item reveal interesting 
differences between disciplines: nearly two-thirds of psychiatrists supported the practice of 
making a diagnosis of depression regardless of whether symptoms occur in response to adverse 
life events (Reed et al., 2011), but only half of psychologists shared this opinion.  Again, this 
difference of opinion may be related to differences in the clinical services provided by 
psychologists.  While psychologists and psychiatrists both recognize the need for mental health 
services in certain cases of depressed, bereaved individuals, these two professions and systems of 
care are associated with different populations of individuals (compare Reed et al., 2011 with 
present study; Pingatore et al., 2002), as well as different theoretical models of mental illness 
(Wyatt & Livson, 1994).  Consistent with a biomedical approach to mental illness and 
healthcare, the provision of psychiatric care may in some cases be predicated upon the presence 
of a psychiatric disorder.  By contrast, psychologists—including counseling, clinical, and other 
specialties—may be more able or likely to provide treatment services such as grief counseling or 
psychotherapy regardless of whether there is a diagnosis.   
Classification within Global Mental Health: Needs and Challenges 
 On questions of cross-cultural applicability, American/European bias, and stigma, 
significantly large differences were found for region but not for DCS used.  Specifically, larger 
proportions of psychologists in Eastern Mediterranean, Africa, and Latin America reported 
problems related to cross-cultural applicability and a DCS being over-embedded in 
American/European customs and values.  These results represent empirical support for the notion 
that the clinicians who have the greatest degree of culture-related difficulties in applying the 
DSM-IV and ICD-10—which are, of course, American and European manuals, respectively—are 
those who live and work outside of the United States and Europe.  Interestingly, this trend was 
somewhat reversed on the question of diagnostic stigma, with Western developed nations 
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expressing more concern about stigmatizing terminology.  However, stigma may carry different 
connotations depending on the cultural context.  That is, the very notion of diagnostic stigma 
presupposes that a sufficient number of persons are actually receiving or living with mental 
health diagnoses to such an extent that would allow for a stigmatizing attitude to take hold within 
a culture.  According to this understanding, it is reasonable to suggest that stigma may be more 
salient in developed nations than in developing nations where the problem of treatment 
availability and access is of primary concern.  Additionally, if stigma is conceptualized as a 
barrier to services, mental health professionals may not be the most accurate reporters because 
they only encounter a treatment-seeking subset of the larger number of individuals in need of 
services.   
 On all of these items, substantial percentages of the overall sample and regional samples 
indicated their agreement that their current DCS can be problematic in relation to cultural 
factors.  However, given the amount of within-group variability, regional differences only depict 
a portion of the story.  National results are more telling.  For example, the relatively high level of 
cultural problems endorsed by psychologists in Lebanon, Turkey, and Israel suggests that DSM-
IV framework (the DCS used by over 75% of respondents in those countries) may be more 
problematic within the cultures of the Eastern Mediterranean than it is in the United States and 
Europe.  Such findings represent significant problems for global mental health care to overcome.  
Further research is needed to better understand the nature of these problems within particular 
countries, as well as how to address them in the ICD-11. 
 Another broad question relating to the development ICD-11 is that of how best to meet 
the needs of different users and stakeholders across a wide variety of cultural and clinical 
contexts.  Given the findings regarding cultural bias and applicability, it is perhaps not surprising 
that there appears to be significant interest in a nation-specific DCS for countries in Latin 
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America, Africa, the Eastern Mediterranean, and, to a lesser extent, Asia.  Regarding clinical 
adaptations, only a slight majority of the overall sample favored a primary care version, and 
regional differences suggest that there may be a greater need for a primary care version in 
regions (e.g., Asia, Africa, Eastern Mediterranean) where mental health conditions are more 
often treated in primary care settings, as opposed to mental health specialty settings.  Given that 
the majority of the global mental health care burden is shouldered by primary care providers 
(Wang et al., 2007; WHO, 2011), a primary care version of the ICD-11 would likely offer 
significant utility in many clinical settings.  Still, one may wonder whether it is reasonable to 
expect a DCS to serve so many purposes (e.g., treatment, research, statistics, reimbursements) 
for so many individuals (e.g., psychologists, psychiatrists, patients, administrative staff) around 
the world, as is the current state of affairs.  Results suggest that majorities of psychologists agree: 
a DCS should be comprehensible to non-professional stakeholders and useful for clinicians from 
a variety of mental health disciplines.  It should be emphasized, however, that these data are 
psychologists’ views as to what physicians, other professionals, and non-professionals prefer.  
Such questions may be more accurately understood through a direct investigation among the 
populations of interest. 
Identifying and Improving upon Problematic Diagnoses 
 Perhaps some of the more interesting aspects of this study are the findings regarding 
psychologists’ use and evaluation of particular diagnostic categories.  Although the average 
number of categories seen regularly was highly variable across countries, psychologists generally 
encounter a relatively small number of disorders on a regular basis, particularly when compared 
to psychiatrists (Reed et al., 2011).  Without accounting for disorder prevalence, psychologists 
appear to have more exposure to disorders related to anxiety, mood, stress reactions, and 
child/adolescent behavior, and relatively less exposure to substance use, psychotic, eating, 
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sexual, and personality disorders.  In other words, psychologists often saw disorders for which 
psychosocial treatments can be effective forms of intervention.  Disorders that were reportedly 
seen with less frequency are those for which medication is often the primary treatment 
component and are thus more likely to be seen by psychiatrists or other physicians.  These 
findings are consistent with previous research on the conditions treated by psychiatrists and 
psychologists (Olfson & Pincus, 1996; Pingatore et al., 2002; Reed et al., 2011). 
 Of particular relevance to the ICD-11 revisions are psychologists’ views on the ease of 
use and goodness of fit of the categories they use most regularly.  First, although most diagnostic 
categories were evaluated relatively favorably, there are several disorders (Table 3) that appear 
to be less useful and/or accurate for the purposes of clinical assessment and treatment.  Many of 
these “problematic” ICD-10 and DSM-IV categories are the ones that might be expected based on 
the volume of literature examining their validity, reliability, and utility as they are currently 
formulated (e.g., Asperger’s disorders, borderline personality disorder, bipolar disorders, impulse 
control disorders, schizoaffective disorders, somatoform disorders); however, these results also 
draw attention to diagnostic entities (e.g., dissociative disorders) that have seen relatively less 
critical attention within the literature, but nevertheless appear to be problematic in clinical 
practice.  These “problematic” categories may warrant a greater degree of attention and 
reformulation during DCS revision processes, or a greater focus on ICD/DSM training efforts.  
Second, those categories that received relatively good ratings (e.g., panic disorders, specific 
phobias, mental retardation, major depressive diagnoses, and eating disorders) should conversely 
be acknowledged as diagnoses that are working relatively well in clinical practice, and therefore 
may not be in need of substantial revisions.   
 Third, differential findings between ICD-10 and DSM-IV categories may suggest relative 
strengths and weaknesses in the respective manuals, whereas areas of agreement may suggest 
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consistent problems with current diagnostic constructs, regardless of DCS.  For example, 
hyperkinetic (attention-deficit/hyperactivity) disorder, antisocial personality disorder, and 
disorders related to the use of volatile solvents and hallucinogens appear to be problematic as 
they are formulated in the ICD-10, but not in the DSM-IV.  Conversely, DSM-IV diagnoses of 
Autistic disorder, tic disorders, sexual dysfunctions, brief psychotic disorders, and primary sleep 
disorders appear to be more clinically problematic than their ICD-10 counterparts.  In the spirit 
of ICD-DSM “harmonisation” (First, 2009; Kupfer, Regier, & Kuhl, 2008), findings such as 
these offer implications for how DCS revisions may draw upon the strengths and weaknesses of 
the diagnostic alternatives among the ICD, DSM, and other systems—if not for the DSM-5 and 
ICD-11, then possibly for subsequent revisions. 
 Lastly, is interesting to note that approximately half of all participants indicated that there 
was one or more disorders with which they were dissatisfied or that they would consider 
problematic in clinical practice; however, when asked about specific actions to be taken, less 
than one-quarter of these participants felt that disorders should be moved around or removed 
altogether, and an even greater number (approximately one-third) felt that disorders should be 
added.  Thus, while a large proportion of psychologists point to disorders that they consider 
problematic, relatively few agree on how best to remedy those problems, and even fewer agree 
on which specific disorders are most problematic.  Indeed, most disorders received relatively 
favorable evaluations for ease of use and goodness of fit.  So it appears that while individual 
psychologists may hold mixed opinions toward the ICD-11 or DSM-IV overall, this may be due 
to a small number of diagnoses viewed as problematic by a small number of clinicians.  When 
one examines the opinions of many mental health professionals across a wide range of 
commonly seen diagnostic categories, it seems that clinicians’ views on ICD-11 and DSM-IV 
categories are in fact more favorable than might be suggested through other methodologies.  
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Certainly, this offers a much more positive picture than the abundance of literature offering 
criticisms and recommendations for changing the DSM and ICD.   
 While these results offer insight into clinicians’ views and preferences, they require 
careful interpretation before leading to any revisions.  For example, the prospect of adding 
disorders or, even failing to move/remove disorders, would necessarily result in a DCS that is 
larger and more complex (i.e., with more diagnostic categories) than what the vast majority of 
clinicians consider to be the optimal (10-100 categories).  And to incorporate additional 
components of severity, functional impairment, or dimensionality would likely have the same 
effect.  These changes would therefore be antithetical to previous criticisms that the DSM-IV and 
ICD-11 are already too large and complex, and therefore need simplification rather than 
expansion (e.g., Flanagan & Blashfield, 2007b, 2010; Watson & Clark, 2006).  Given these 
mixed findings and recommendations, these results should be interpreted cautiously and 
collectively.  Any revisions made to the ICD-11 should only be made after a careful 
consideration of the views and needs of the diverse population of global psychologists. 
Limitations 
 Although the entire sample is quite sizable, this study’s primary limitations are related to 
issues of participant selection and representativeness. First, because participants were solicited 
through their membership in national psychological associations (possibly the only means 
through which such a study could feasibly be conducted), they may not be representative of the 
larger populations within each country.  Relatedly, countries without professional organizations 
could not be represented at all.  Second, the majority of participants were from high income and 
European countries, and participation from other regions and developing nations was 
comparatively low.   Third, due to disparities among sample sizes within regional and DCS 
groups, findings should not be interpreted as representative of all countries within a given region, 
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or all users of a particular DCS; rather, the generalizability of these findings may be limited to 
psychologists in the 23 countries represented.  In particular, results for very low-N countries 
(e.g., Zimbabwe, Namibia) should be interpreted with extreme caution.   
 However, these differences are reflective of larger disparities in the prevalence of mental 
health professionals in developed versus developing nations (WHO, 2011) as well as the degree 
to which professional psychology is defined, regulated, and organized at the national level 
(Stevens & Wedding, 2004).  Thus, the gold standard of “representativeness” is an elusive goal 
for any purportedly “global” survey to achieve.  Nevertheless, by reporting the aggregated results 
in total and with each country given equal weight, it is possible to examine the extent to which 
these sample size differences affect the results and to arrive at a more representative estimate.  
Related to the issue of sample size is that of the data on particular diagnostic categories.  Because 
categories were evaluated only by clinicians who saw them regularly, the results for diagnoses 
with fewer respondents (e.g., Inhalant-Related Disorders; see Figures 8 and 9) should be 
interpreted as less reliable than those with more ratings (e.g., Major Depressive disorder). 
 In light of the variability of professional psychology around the globe (Stevens, & 
Wedding, 2004), a further limitation is that data were not collected on participants’ educational 
qualifications (e.g., bachelor’s, master’s, or doctoral degrees), type and quality of training, or 
professional practices.  Such factors should be examined in future research, as they are likely to 
play a significant role in psychologists’ experiences and views regarding classification and 
diagnosis.  Finally, it should be reiterated that these findings are not to be interpreted to as 
realities of global mental health care.  Rather, they represent the experiences and opinions of 
psychologists in relation to the diverse contexts in which they practice. 
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Implications and Future Directions 
 To date, this investigation represents the second largest clinician survey on the diagnostic 
classification of mental disorders, as well as the first study of its kind to be conducted among a 
truly global sample of psychologists.  Given that most similar studies, whether at the national or 
international level, have been conducted among psychiatrists (e.g., Mellsop et al., 2007a, 2007b, 
2011; Suzuki et al., 2010; Zielasek et al., 2010), this survey offers new insights into the views 
and practices of a previously unexamined professional population within global mental health 
care.  Notably, the online format of the survey allowed for greater participation from 
professionals in developing regions, such that low and lower-middle income nations exhibited 
the highest response and completion rates.  Indeed, open-ended responses from these participants 
reflected their gratitude and enthusiasm for participating in this project.  In light of the growing 
ubiquity of Internet access among health professionals even in developing nations, as well as the 
increasing collaboration among national and international mental health organizations, studies 
such as this provide examples of how practitioner research can be conducted at the global level 
quite feasibly and successfully. 
 In very practical terms, these findings offer several direct implications for the 
development of the ICD-11.  First, they are one of several sources of data that are currently being 
used to inform revisions to the ICD, both for specific diagnostic categories as well as for broad, 
cross-cutting issues of diagnostic classification.  For example, these findings suggest that the 
ICD-11 should: (a) be designed primarily for the purposes of clinical treatment, management, 
and communication; (b) contain flexible diagnostic guidelines and, if possible, fewer categories; 
(c) be useful and comprehensible to mental health clinicians of all backgrounds, patients, 
administrative staff, advocates, etc.; and (d) address considerations of severity, dimensionality, 
functional impairment.  However, this is not to say that these revisions are democratically 
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determined; this study was not intended to give psychologists a “vote,” per se, in shaping the 
ICD-11 (in fact, the results contain so many mixed findings and disagreements that such a 
misguided approach would be fruitless).  Rather, this study offers a glimpse into the preferences 
and opinions of psychologists, which will be used, along with other sources of data (e.g., Reed et 
al., 2011, 2012; Roberts et al., 2012), to inform the decisions made by well-qualified individuals 
within the ICD-11 work, advisory, and coordinating groups.  
 Second, these results will serve as baseline data to help direct future research on the 
clinical utility, reliability, and validity of ICD-11 categories.  This bears the most immediate 
relevance for the ICD-11 field trials.  The present investigation was a part of the ICD-11 
formative research program, and was conducted on the hypothesis that if the ICD can be revised 
to correspond more closely with clinicians’ needs, preferences, and experiences, the result would 
be improvements not only in clinical utility and care, but also in reliability and validity.  These 
are empirical questions.  Soon they will be investigated within the summative research program 
of the ICD-11 development process.  This next phase includes field trials and other studies, 
which will aim to evaluate and improve the reliability, validity, and utility of the new system. 
 Third, in addition to implications for changing the ICD-11 system, these findings offer 
direction to help facilitate effective ICD-11 dissemination, adaptation (e.g., national DCSs, 
primary care version), translation, and training efforts around the globe.  Finally, in anticipation 
of the DSM-5 and ICD-11, the present study offers a better understanding of psychologists’ 
views and practices regarding diagnostic classification and provides direction for further 
international research among psychologists and clinicians.  Indeed, a great deal of research is 
needed to better understand the unique sociocultural and medical factors (e.g., stigma, treatment 
access) at play within each country, as well as ways to improve mental health service delivery 
around the globe.  Toward that end, WHO’s Department of Mental Health and Substance Use is 
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currently preparing for the next phase of ICD-11 research.  Building upon the findings of the 
present study, these investigations will hopefully help to bring about a diagnostic system which, 
compared to its predecessors, is more valid, reliable, and clinically useful within the challenging 
context of global mental health care.  
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Appendix 
 
The WHO-IUPsyS Online Survey for Psychologists (English Generic Version) 
 
[Introduction Page] 
                                                                                                    
 
Dear Colleague, 
 
The (NAME) Psychological Association is collaborating with the International Union of Psychological Science (IUPsyS) and the 
World Health Organization (WHO) in order to provide input into WHO's revision of the International Classification of Diseases 
and Diseases and Related Health Problems, 10th Revision (ICD-10) currently underway. More specifically, IUPsyS is working 
with WHO on the revision of the ICD-10 chapter on Mental and Behavioural Disorders. 
 
WHO and IUPsyS are engaging in an international and multilingual process in order to assess the views and opinions of 
psychologists around the world regarding the problems with current classification systems and how their clinical utility can be 
improved. WHO has a commitment that the revision process represent multidisciplinary perspectives, including those of 
psychologists, and IUPsyS is represented on the International Advisory Group charged with assisting WHO with the revision. 
This is the first time that psychologists have played such an active role in preparing the new classification for mental and 
behavioural disorders. 
 
WHO expects to publish the ICD-11 in 2014. Throughout the revision process, and with the support of its members, the (NAME) 
Psychological Association will work with IUPsyS and WHO to provide scientific and clinical input in order to strengthen, 
broaden, and improve the ICD-11 classification system. 
 
One specific way in which the (NAME) Psychological Association, IUPsyS and WHO are collaborating is through this on-line 
survey. This is only the first of a series of opportunities for the (NAME) Psychological Association to participate in the revision 
of the ICD-10, which will involve a systematic program of surveys and field studies. WHO and IUPsyS are taking advantage of 
technology that did not exist at the time the ICD-10 was developed in order to make this survey available and accessible to 
psychologists throughout the world. 
 
We are asking you to complete this survey, answering each question as honestly and as accurately as possible. The survey should 
take approximately 20 minutes to complete. Most of the questions relate to your own views and opinions, based on your day–to-
day clinical experience. There are no right or wrong answers. 
 
This survey is designed for psychologists who provide services to patients or clients (e.g., assessment or treatment services) in a 
variety of settings. Even if you do not currently use a classification system for mental disorders as a normal part of your practice 
or if you do not typically make the diagnosis yourself, your input regarding the desirable characteristics of a classification system 
and other general issues will still be important. If you normally use another classification system, such as the American 
Psychiatric Association's Diagnostic and Statistical Classification of Mental Disorders (DSM-IV), we would still request that you 
participate in the survey. In fact, the DSM-IV is also currently undergoing revision, and both WHO and the American Psychiatric 
Association have stated as an explicit goal of their respective revision processes to improve the harmonization of ICD-11 and 
DSM-5. Your participation will contribute to that process. 
 
Your participation in this survey is strictly voluntary. The information you provide will be used for the purposes of this study 
only and will be reported only in aggregated form. This survey contains no questions that can potentially identify you or your 
patients, and your name will not be associated in any way with the research findings. It is possible, however, with internet 
communications, that through intent or accident someone other than the intended recipient may see your response. 
 
The content of the questionnaire should cause no more discomfort than you would experience in your everyday life. Although 
participation may not benefit you directly, we believe that the information obtained from this study will help us gain a better 
understanding of psychologists' views of ICD and issues related to the classification of mental and behavioural disorders. 
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We are grateful for your interest and your participation in this study. If you have questions or comments, please send them to Dr. 
Patricia Esparza, Department of Mental Health and Substance Abuse, World Health Organization at esparzap@who.int. 
 
Thank you very much for your participation and support. 
 
WHO and IUPsyS are working with investigators at the University of Kansas, U.S. to be able to provide this internet survey. 
WHO, IUPsyS, and the University of Kansas support the practice of protection for human subjects participating in research.  The 
investigators for this study include Dr. Geoffrey M. Reed, WHO, Dr. Pierre Ritchie and Dr. Ann Watts, IUPsyS, and Dr. Michael 
C. Roberts, University of Kansas. The preceding information is provided for you to decide whether you wish to participate in 
survey. If you have additional questions about your rights as a research participant, you may call +1 785 864 7429, write the 
Human Subjects Committee Lawrence Campus (HSCL), University of Kansas, 2385 Irving Hill Road, Lawrence, Kansas 66045-
7563, USA, or email mdenning@ku.edu. 
 
Approved by the Human Subjects Committee University of Kansas, Lawrence Campus (HSCL). Approval expires one year from 
30 April 2010. HSCL #18718. 
 
Exempted from review by the World Health Organization Research Ethics Review Committee, 26 March 2010. Protocol ID 
RPC394. 
 
If you agree to participate in this WHO-sponsored survey, and wish to proceed, please click on the 'Yes' button below. Clicking 
on the 'Yes' button indicates your willingness to participate in this survey, that you are a psychologist, and that you are qualified 
or licensed to practice as a psychologist in your country. 
 
If you do not want to participate, please close this browser window to leave the survey website. 
 
I agree to participate in this study: 
a. Yes 
b. No 
 
[Section One] 
 
1. Country of residence 
2. Year of birth 
3. Gender 
4. Years of professional experience (after qualifying or being licensed as a psychologist) 
5. Are you licensed or otherwise authorized by your country, state, or province to provide assessment or treatment services to 
persons with mental and behavioural disorders?  
a. Yes, independently 
b. Yes, under supervision 
c. No 
6. Do you currently see patients or clients as part of your regular professional activities? 
a. Yes 
b. No 
7. During a typical week, how many hours do you spend seeing patients or clients? 1 
a. None 
b. Between 1 and 9 hours 
c. Between 10 and 19 hours 
d. Between 20 and 40 hours 
                                                 
1 
Item displayed only if respondent: (a) is currently seeing patients/clients. 
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e. More than 40 hours 
8. In the settings where you normally practice, who is responsible for making individual diagnoses? 1 
a. Psychologists 
b. Psychiatrists 
c. Other physicians 
d. Nurses 
e. Other 
9. In the one setting where you practice most, what role do you as a psychologist play in making individual diagnoses? 1 
a. I make diagnoses independently 
b. I contribute to diagnostic formulations made by other health professionals 
c. I have no active role in making diagnoses 
d. Other 
10. As part of your day-to-day clinical work, how much of the time do you use a formal classification system for mental 
disorders, such as the ICD-10, the DSM-IV, the ICD-9 or ICD-9-CM, or a national classification? 1 
a. Almost always/Always 
b. Often 
c. Sometimes 
d. Rarely 
e. Never 
11. In your day-to-day clinical work, which classification system for mental disorders do you use most? 2 
a. ICD-10 
b. DSM-IV 
c. ICD-9 or ICD-9-CM 
d. Other diagnostic system (specify) 
12. Which of the following best describes how familiar you are with the ICD-10 classification of mental and behavioural 
disorders? 3 
a. NOT AT ALL or ALMOST NOT AT ALL (e.g., you have not reviewed or studied the ICD-10 in detail and have 
only a vague idea of its structure and contents) 
b. A LITTLE (e.g., you are familiar with the basic structure and contents of the ICD-10) 
c. SOMEWHAT FAMILIAR (e.g., you have some experience with the ICD-10 in clinical settings and/or a general 
understanding of its categories, definitions, and descriptions) 
d. QUITE FAMILIAR (e.g., you have substantial experience with the ICD-10 in clinical settings and/or a detailed 
understanding of its categories, definitions, and descriptions) 
 
[Section Two] 
 
13. From your perspective, which is the single, most important purpose of a diagnostic classification system?  
a. To serve as a reliable tool for communication between clinicians 
b. To facilitate communication between clinicians and service users/patients 
                                                 
1
 Item displayed only if respondent: (a) is currently seeing patients/clients.
 
2
 Item displayed only if respondent: (a) is currently seeing patients/clients; and (b) uses a diagnostic classification system at least “Rarely”. 
3
 Item displayed only if respondent: (a) is currently seeing patients/clients; (b) uses a diagnostic classification system at least “Rarely”; and (c) uses a 
diagnostic system other than the ICD-10. 
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c. To inform decisions about treatment and clinical management 
d. To facilitate research 
e. To serve as a basis for generating national health statistics 
f. Other (please describe): 
14. In clinical settings, how many diagnostic categories should a classification system contain to be most useful for mental 
health professionals?   
a. 10 to 30 diagnostic categories 
b. 31 to 100 diagnostic categories 
c. 101 to 200 diagnostic categories 
d. More than 200 diagnostic categories 
15. Primary care practitioners should have: 
a. A modified/simpler classification system of mental disorders  
b. The same classification system as specialist mental health professionals  
16. Please rate the extent to which you agree with the following statement: “A diagnostic classification system should serve as a 
useful reference not only for psychiatrists but for all mental health professionals (e.g., psychologists, social workers, 
psychiatric nurses).” 
a. Do not agree 
b. Agree somewhat 
c. Mostly agree 
d. Completely agree 
17. Please rate the extent to which you agree with the following statement: “A diagnostic classification system should be 
understandable to service users, patient advocates, administrators, and other relevant people as well as to health 
professionals.” 
a. Do not agree 
b. Agree somewhat 
c. Mostly agree 
d. Completely agree 
18. For maximum utility in clinical settings, a diagnostic manual should contain: 
a. Clear and strict (specified) diagnostic criteria for all disorders  
b. Diagnostic guidance that is flexible enough to allow for cultural variation and clinical judgment 
19. The best way for a diagnostic system to address the concept of severity would be: 
a. To provide subtypes of relevant diagnostic categories (e.g., mild, moderate or severe depressive episode), based on 
the number and/or severity of symptoms present.  
b. To provide subtypes of relevant diagnostic categories, based on the degree of functional impairment (e.g., 
impairment in self-care or occupational functioning).  
c. To provide a separate axis allowing an overall assessment of severity that could be used for all diagnoses.  
d. Not to try to include it; severity is an important part of clinical assessment but does not need to be part of the 
diagnostic classification. 
20. What is the best way for a diagnostic system to conceptualize the relationship between diagnosis and functional status (e.g., 
impairment in self-care or occupational functioning)?  
a. Functional impairment should be a diagnostic criterion for most mental disorders; if there is no functional 
impairment, then a disorder should not be diagnosed. 
b. Functional status should be a diagnostic criterion for some mental disorders, when it is necessary to infer the 
presence of a disorder from its functional consequences. 
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c. Functional status should not be included in diagnostic criteria; functional impairments are more properly viewed 
as consequences or outcomes of mental disorders. 
21. Should a diagnostic system incorporate a dimensional component, where some disorders are rated on a scale rather than 
just as present or absent?  
a. YES, because this would make the diagnostic assessment more detailed and personalized. 
b. YES, because this would more accurately reflect the continuous nature of the underlying psychopathology. 
c. NO, because this would be too complicated for use in most clinical settings. 
d. NO, because there is insufficient research evidence regarding the reliability of a dimensional approach. 
22. Should the diagnosis of depression be assigned when the depressive symptoms are a proportionate response to an adverse 
life event (e.g., loss of job or home, divorce)? 
a. NO, a proportionate response to an adverse life event should not be considered a mental disorder. 
b. YES, if the full depressive syndrome is present, the diagnosis should be made regardless of whether there are life 
events that can potentially explain it. 
23. Please rate the extent to which you agree with the following statement based on your day to day clinical experience: “The 
diagnostic system I use is difficult to apply across cultures, or when the patient/service user is of a different cultural or 
ethnic background from my own.” 2 4 
a. Do not agree 
b. Agree somewhat 
c. Mostly agree 
d. Completely agree 
24. Please rate the extent to which you agree with the following statement based on your day to day clinical experience: “The 
diagnostic system I use is problematic because it is over-embedded in U.S. and European culturally-derived concepts and 
values.” 2 
a. Do not agree 
b. Agree somewhat 
c. Mostly agree 
d. Completely agree 
 
[Section Three] 
 
25a. The following questions relate to your use of the ICD-10 diagnostic categories for mental disorders. 4 
Of the ICD-10 diagnostic categories listed below, please indicate which ones you use once a week or more in your day-to-
day clinical practice (that is, you see a patient or client with that diagnosis at least once a week), whether or not you 
personally assign the diagnosis. 
1. F00 Dementia in Alzheimer's disease 
2. F01 Vascular dementia 
3. F05 Delirium, not induced by alcohol and other psychoactive substances 
4. F10 Mental and behavioural disorders due to the use of alcohol 
5. F11 Mental and behavioural disorders due to the use of opioids 
6. F12 Mental and behavioural disorders due to the use of cannabinoids 
7. F13 Mental and behavioural disorders due to the use of sedatives or hypnotics 
8. F14 Mental and behavioural disorders due to the use of cocaine 
9. F15 Mental and behavioural disorders due to the use of other stimulants 
10. F16 Mental and behavioural disorders due to the use of hallucinogens 
11. F18 Mental and behavioural disorders due to the use of volatile solvents 
                                                 
2
 Item displayed only if respondent: (a) is currently seeing patients/clients; and (b) uses a diagnostic classification system at least “Rarely”. 
4
 Item displayed only if respondent: (a) is currently seeing patients/clients; (b) uses a diagnostic classification system at least “Rarely”; and (c) uses the 
ICD-10. 
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12. F20 Schizophrenia 
13. F21 Schizotypal disorder 
14. F22 Persistent delusional disorder 
15. F23 Acute and transient psychotic disorder 
16. F25 Schizoaffective disorder 
17. F30 Manic episode 
18. F31 Bipolar affective disorder 
19. F32 Depressive episode 
20. F33 Recurrent depressive disorder 
21. F40.0 Agoraphobia 
22. F40.1 Social phobia 
23. F40.2 Specific (isolated) phobias 
24. F41.0 Panic disorder 
25. F41.1 Generalized anxiety disorder 
26. F41.2 Mixed anxiety and depressive disorder 
27. F42 Obsessive-compulsive disorder 
28. F43.1 Post-traumatic stress disorder 
29. F43.2 Adjustment disorder 
30. F44 Dissociative [conversion] disorders 
31. F45 Somatoform disorders 
32. F50.0 Anorexia nervosa 
33. F50.2 Bulimia nervosa 
34. F51 Nonorganic sleep disorder 
35. F52 Sexual dysfunction 
36. F60.2 Antisocial personality disorder 
37. F60.31 Borderline personality disorder  
38. F63 Habit and impulse disorders 
39. F7 Mental retardation (i.e., intellectual disability) 
40. F84.0 Childhood autism 
41. F84.5 Asperger's syndrome 
42. F90 Hyperkinetic (attention deficit) disorder 
43. F91 Conduct disorders, including oppositional defiant disorder 
44. F95 Tic disorders 
45. Other – Please specify: 
46. Other – Please specify: 
47. None of the above 
25b. Please evaluate the ICD-10 diagnostic categories you previously selected by making a rating of each category on two 
dimensions: 1) ease of use of the DSM-IV diagnostic criteria for that category or group of disorders; and 2) goodness of fit 
or accuracy of the DSM-IV definition, description, and diagnostic criteria in describing the patients or clients you see in 
clinical practice. 5 
Please use the following scales for making your ratings: 
EASE OF USE of the ICD-10 diagnostic criteria: 
0 = Not at all easy to use in clinical practice 
1 = Somewhat easy to use 
2 = Quite easy to use 
3 = Extremely easy to use 
GOODNESS OF FIT in clinical practice (accuracy in describing patients): 
0 = Not at all accurate 
1 = Somewhat accurate 
2 = Quite accurate 
3 = Extremely accurate 
                                                 
5
 Item displayed only if respondent: (a) is currently seeing patients/clients; (b) uses a diagnostic classification system at least “Rarely”; (c) uses the 
ICD-10; and (d) sees at least one ICD-10 diagnostic category regularly.  Additionally, respondents only rated the categories they see regularly. 
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26a. The following questions relate to your use of the DSM-IV diagnostic categories for mental disorders. 6 
Of the DSM-IV diagnostic categories listed below, please indicate which ones you use once a week or more in your day-to-
day clinical practice (that is, you see a patient or client with that diagnosis at least once a week), whether or not you 
personally assign the diagnosis. 
1. Mental Retardation (i.e., Intellectual Disability)    
2. Autistic Disorder    
3. Asperger's Disorder    
4. Attention-Deficit/Hyperactivity Disorder    
5. Conduct Disorder    
6. Tic disorders    
7. Delirium Due to General Medical Condition   
8. Dementia of the Alzheimer's Type    
9. Vascular Dementia    
10. Alcohol-Related Disorders    
11. Amphetamine (or Amphetamine-Like)-Related Disorders    
12. Cannabis–Related Disorders    
13. Cocaine–Related Disorders    
14. Hallucinogen–Related Disorders    
15. Inhalant–Related Disorders    
16. Opioid–Related Disorders    
17. Sedative, Hypnotic, or Anxyolitic–Related Disorders    
18. Schizophrenia   
19. Schizoaffective Disorder    
20. Delusional Disorder    
21. Brief Psychotic Disorder    
22. Major Depressive Disorder    
23. Single Major Depressive Episode    
24. Bipolar I Disorder    
25. Single Manic Episode 
26. Bipolar II Disorder 
27. Panic Disorder Without Agoraphobia 
28. Panic Disorder With Agoraphobia 
29. Agoraphobia Without History of Panic Disorder 
30. Specific Phobia 
31. Social Phobia 
32. Obsessive–Compulsive Disorder 
33. Post-Traumatic Stress Disorder 
34. Generalized Anxiety Disorder 
35. Somatoform Disorders 
36. Dissociative Disorders 
37. Sexual Dysfunctions 
38. Anorexia Nervosa 
39. Bulimia Nervosa 
40. Primary Sleep Disorders 
41. Impulse Control Disorders Not Elsewhere Classified 
42. Adjustment Disorders 
43. Schizotypal Personality Disorder 
44. Antisocial Personality Disorder 
45. Borderline Personality Disorder 
46. Other – Please specify: 
47. Other – Please specify: 
48. None of the above 
26b. Please evaluate the DSM-IV diagnostic categories you previously selected by making a rating of each category on two 
dimensions: 1) ease of use of the DSM-IV diagnostic criteria for that category or group of disorders; and 2) goodness of fit 
or accuracy of the DSM-IV definition, description, and diagnostic criteria in describing the patients or clients you see in 
clinical practice. 7 
                                                 
6
 Item displayed only if respondent: (a) is currently seeing patients/clients; (b) uses a diagnostic classification system at least “Rarely”; and (c) uses the 
DSM-IV. 
7
 Item displayed only if respondent: (a) is currently seeing patients/clients; (b) uses a diagnostic classification system at least “Rarely”; (c) uses the 
DSM-IV; and (d) sees at least one DSM-IV diagnostic category regularly. Additionally, respondents only rated the categories they see regularly. 
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Please use the following scales for making your ratings: 
EASE OF USE of the ICD-10 diagnostic criteria: 
0 = Not at all easy to use in clinical practice 
1 = Somewhat easy to use 
2 = Quite easy to use 
3 = Extremely easy to use 
GOODNESS OF FIT in clinical practice (accuracy in describing patients): 
0 = Not at all accurate 
1 = Somewhat accurate 
2 = Quite accurate 
3 = Extremely accurate 
 
[Section Four] 
 
27. Are there diagnostic categories with which you are especially dissatisfied, or that you believe are especially problematic in 
terms of their goodness of fit in clinical settings? 
a. Yes 
b. No 
If yes, please explain: 
28. Are there any specific diagnoses in that you feel should be removed or moved to another section?  
a. Yes 
b. No 
If yes, please explain: 
29. Are there any specific diagnostic categories that you feel should be added to the classification system for mental disorders? 
a. Yes 
b. No 
If yes, please explain:  
30. Do you think that any of the terms used in current diagnostic systems are stigmatizing in your language or cultural context? 
a. Yes 
b. No 
If yes, please explain: 
31. Do you see the need in your country for a national classification of mental disorders (i.e., a country-specific classification 
that is not just a translation of ICD-10)? 
a. Yes 
b. No 
If yes, please explain: 
32. Please use this space to provide any comments you have about this survey overall: 
